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1. Introduction 
 
Acetylcholinesterase (AChE) is known as the enzyme that terminates the action of 
the neurotransmitter acetylcholine (ACh) at cholinergic synapses. However, an increasing 
number of scientific works showed that AChE has functions other than the hydrolysis of 
ACh, related to cell differentiation, synaptogenesis, neuronal signaling and diseases. These 
functions are well documented, but the mechanism that supports them is not really 
elucidated. The aim of this thesis was to find a possible mechanism that supports 
developmental functions of AChE. For this it was hypothesized that AChE functions as a 
heterophilic cell adhesion molecule which sends signals into the neurons by binding to a 
membrane receptor, and searched for AChE–binding partners. 
 
1.1. Cholinergic transmission includes a very fast and specific 
enzyme - AChE 
 
AChE is a serine hydrolase and belongs to the fastest enzymes known, with the 
hydrolysis of ACh approaching the maximal theoretical limit set by molecular diffusion of 
substrate (Quinn, 1987). Acetylcholine hydrolysis can also be catalyzed by BChE, which is a 
close structural relative of AChE. These proteins share ~ 50% homology, concentrated in 
the catalytic region, but they differ in their substrate specificity (Chatonnet and Lockridge, 
1989). AChE is selective towards ACh hydrolysis, which it can perform at a rate of over 
10000 molecules per second. In contrast, BChE is much slower, and can also hydrolyze 
higher choline esters, particularly butyrylcholine. However, AChE has more functions than 
the ACh hydrolysis and the focus of this work is to understand one of these AChE “non-
classical” functions. 
 
Structure 
 
Prior to 1991, the structure of AChE had been based on chemical primary 
sequences. Sussman and co-workers systematically cleaved amino acid sections from the 
C-terminus of the native protein (from Torpedo), ultimately succeeding in elucidating the 
crystal structure of AChE (Sussman et al., 1991). This structure revealed a molecule with a 
α/β hydrolase fold similar to other esterases and lipases. Figure 1 shows that AChE is a 
globular glycoprotein, with the active site located 4 Å above the bottom of a 20 Å deep, 
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narrow gorge (Bourne et al., 1995). The active site comprises the ``esteratic site``, 
containing the catalytic triad (Ser, His, Glu) with the active site serine responsible for 
hydrolysis, and the ``anionic site`` which binds the quaternary ammonium ion of 
acetylcholine (Radic et al., 1997). The gorge is lined with 14 aromatic residues, forming a 
second or ``peripheral anionic site`` (PAS) (Taylor and Radic, 1994). Binding of a ligand at 
the PAS of AChE may cause conformational changes important in the functioning of the 
enzyme. PAS binds cholinesterase inhibitors selectively (Changeux, 1966; Taylor and 
Lappi, 1975) and these ligands can impede substrate entry to the active centre and also 
additionally exert an allosteric influence on the conformation of AChE (Falkenstein and 
Pena, 1997). It has been reported repeatedly that inhibition of this site can not only alter 
cholinergic activity but also modify neurite outgrowth (Bataillé et al., 1998), amyloid beta 
association (Inestrosa et al., 1996) and adhesion properties (Johnson and Moore, 1999). 
It was shown that an electrostatic dipole exists through the AChE molecule 
(Shafferman et al., 1992a) and this can contribute to the cholinergic and non-cholinergic 
functions of the AChE. Electrostatic mechanisms could help to interpret the fast substrate 
access (Radic et al., 1997) and the enzyme’s role as a cell adhesion molecule 
(electrotactins) (Botti et al., 1998).  
 
Genetics of AChE 
 
Mammals possess only two cholinesterase genes, an ACHE and a BCHE gene, with 
a single open reading frame. The mouse ACHE is situated on chromosome 5 (Rachinsky et 
al., 1990; Li et al., 1991, Rachinsky et al., 1992). Three invariant exons of ACHE (exon 2, 3 
and 4, with exon 1 not being transcribed) encode the signal peptide and the N-terminal 535 
amino acids common to all forms of the enzyme, whereas alternative exon usage of the 
next exons (5 and 6) accounts for structural divergence in the C-terminus (Rachinsky et al., 
1990; Li et al., 1991). The AChE gene generates multiple types of transcripts through a 
combination of different processes: the choice of several promoters; alternative splicing in 
the 5’-untranslated region (Luo et al., 1998; Atanasova et al., 1999); alternative splicing at 
the 3’-extremity of the coding region (Li et al., 1991); the choice of several polyadenylation 
sites, and variable lengths of the 3’-untranslated sequence (Massoulie et al., 1993). The 
alternative splicing generates AChE with 3 different C-terminal domains: -H (hydrophobic), -
R (read-through: not spliced) and -T (tailed) (Massoulié et al., 1998). The C-terminal domain 
determines the post-translational processing, quaternary organization and anchoring of the 
enzyme, and thus, ultimately where the enzyme will be located.  
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Multiple molecular forms for AChE, assembly, secretion 
 
The two spliced variants of AChE, H and T, are homomeric and may form multiple 
globular subunit associations, G1, G2, G4, etc. (see Figure 2) (Massoulié et al., 1993).The 
R-form does not seem to have any feature that allows for its attachment to other molecules 
and remains monomeric and soluble. The C-terminus of the H-form allows it to form 
disulfide–linked glycophospholipid–anchored dimers, which may be released by cleavage 
from the membrane. The C-terminus of the T-form permits diverse interactions. The AChE-
T forms monomers and disulfide-bound dimers, which can be membrane-anchored or 
secreted in the case of proteolytic cleavage at the C-terminus. 
 
 
Figure 1. The structure of acetylcholinesterase and its catalytic reaction. (Soreq and 
Seidman, 2001, Nature Neuroscience) (a) Structural properties of the enzyme: note the active site, 
placed in a deep gorge and the peripheral anionic site. (b) The AChE reaction. AChE hydrolyses 
ACh by forming an acetyl-AChE intermediate with the release of choline, followed by the hydrolysis 
of the intermediate to release acetate. 
 
Additional hydrophobic interactions allow the formation of tetramers, which can be 
soluble or attached to the membrane by heteromeric associations with a PRiMA anchor 
(proline rich membrane anchor) (Perrier et al., 2002) or a collagen-like tail. The multiple 
molecular forms possess similar catalytic properties, but differ in their oligomeric assembly 
and the mode of attachment to the cell surface (see Figure 2).  
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There are two classes of molecular forms: 
 
• The heteromeric species in which the catalytic units are linked to the structural units, 
including the asymmetric forms in which 8-12 hydrophilic catalytic subunits are 
associated with collagen-containing subunits through disulfide bonds. 
• The homomeric species which can be subdivided into soluble and amphiphilic forms. 
The amphiphilic forms possess a glycophospholipid (GPI) attachment that interacts 
with the cell membrane. 
 
The globular form of AChE is assembled in the rough endoplasmic reticulum with the 
assembly of asymmetric forms occurring approx. 90 minutes later in the distal elements of 
the Golgi apparatus (Massoulié et al., 1993). Once processed, AChE is packaged in coated 
vesicles and transported to the plasma membrane, where the vesicles fuse and result in 
either secretion of AChE or insertion of AChE into the membrane (Rotundo, 1990). The 
molecular diversity of AChE is not only important for cholinergic transmission but also for the 
non-cholinergic functions (see later). 
 
 
Figure 2. The major oligomeric forms of AChE. The catalytic subunit types are identified by T 
or H. The molecular form is labeled above. G-globular; A-asymmetric. 
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1.2. AChE is a multifunctional protein 
 
AChE has been examined extensively in the last century and the idea that AChE has 
multiple, unrelated biological functions was slowly being accepted. Multiple reviews 
attempted to give an insight into these functions (Layer and Willbold, 1995; Small et al., 
1996; Soreq and Seidman, 2001).  
 
These functions can be classified as below: 
1. enzymatic cholinolytic functions (hydrolysis of ACh); 
2. enzymatic, non-cholinolytic functions (side activities e.g. arylacylamidase activity); 
3. non-enzymatic functions (e.g. adhesion, developmental functions). 
 
Point 1 represents the classical function of the enzyme, while 2 and 3 are named non-
classical or non-cholinergic functions.  
 
1.2.1. The classical cholinergic side of AChE 
 
The effective concentration of neurotransmitter ACh at the neuromuscular endplate 
and in the central nervous system will be predominantly regulated by the enzyme AChE, 
which is localized externally on neurites and growth cones, and also can be released into 
the developing synaptic cleft (see also 1.1.). 
 
1.2.2. Non–classical functions of AChE 
 
The following experimental evidence supported the concept of non-classical 
functions of AChE: 
 
a. In 1956 Hebb demonstrated that the distribution of choline acetyl-transferase 
(ChAT) was closely correlated with the distribution of ACh (Hebb, 1956). It might be 
expected that AChE would similarly localize with ACh, however, a detailed study of the 
mismatch of AChE- and ChAT- positive structures in the brain indicates that AChE may not 
only be functioning to hydrolyze ACh (Eckenstein and Sofroniew, 1983). This was the first 
line of evidence that indicated that AChE may have non-classical functions. 
b. High levels of AChE can be detected in the embryonic nervous system well before 
the period of synaptogenesis (Layer 1983, 1991; Layer et al., 1988a; Robertson et al., 
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1989). The embryonic expression does not necessarily lead to the expression of the 
enzyme in the same adult tissues. 
c. In paragraph 1.1. the existence of the multiple molecular forms was discussed. 
The existence of the multiple isoforms of AChE remains unclear if the enzyme has only a 
single function. 
d. Crystallography and sequence analysis have identified a group of related enzymes 
and non-catalytic proteins. Some of these are transmembrane proteins with cytoplasmic 
domains and extracellular AChE-homologous domains that share the unique topography of 
AChE and its strong electric field. On the basis of their structures, all of these are classified 
as α/β–fold proteins; on the basis of their electric fields they are classified as electrotactins 
(Botti et al., 1998). 
e. AChE has been shown to have direct actions on several types of cells, actions 
unrelated to a neurotransmission role, e.g. modulation of the neuronal sensitivity (Greenfield 
et al., 1984; Greenfield, 1991).  
 
Some of the non-classical functions are based on the correlations, other activities 
have been confirmed and several research groups have established their molecular 
foundation. The most established ones are discussed below. 
AChE regulates neurite outgrowth. The expression of AChE precedes the 
outgrowth of processes in cultured spheroids (Layer et al., 1988b; Weikert et al., 1990) and 
in non-cholinergic neurons in the rat thalamus (Kristt, 1989). AChE inhibitors changed 
neurite growth from chick nerve cells in culture, independent of its enzymatic activity (Layer 
et al., 1993). Active-site inhibitors failed to attenuate this effect, but an inhibitor of the 
peripheral site did block neuritogenesis (Layer et al., 1993; Small et al., 1995). Transfection 
with AChE showed neuritogenic activity of the enzyme in the neuroblastoma cells 
(Koenisgberger et al., 1997), in phaeochromocytoma (PC12) cells (Grifman et al., 1998) and 
in primary dorsal root ganglion neurons (Bigbee et al., 2000). 
Synaptogenesis. AChE is transiently expressed by thalamocortical axons just prior 
to synaptogenesis (Robertson, 1987). Increased levels of AChE are detected in maturing 
neurons in chick spinal cord and in their target myotomes prior to the arrival of axons (Layer 
et al., 1988a). Thus, axonal pathfinding may be regulated by AChE expression. In the 
Xenopus brain, AChE stimulates the development of axon tracts (Anderson and Key, 1999). 
However, a direct synaptogenic activity was shown for neuroligin, a non-catalytic 
transmembrane protein that has an AChE homologous extracellular domain (Scheiffele et 
al., 2000). When expressed in HEK293 cells, neuroligin induced synaptic vesicle clustering 
and presynaptic differentiation in adjacent axons. The effect was prevented by the addition 
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of the extracellular domain of neurexin-1β, a binding partner for neuroligin (Ichtchenko et al., 
1996), which could presumably bind AChE too. This evidence supports the idea that the 
synaptogenetic role of AChE is probably related to structural properties of the molecule, and 
not the catalytic function. 
Cell adhesion. A cell adhesion function of AChE might provide a mechanism for 
developmental roles of this protein. There are three major groups of cell adhesion 
molecules localized on the axonal surface: the cadherins, the integrins, and the members of 
the immunoglobulin family. Like AChE, these molecules are expressed by the nerve cells 
prior to synaptogenesis and are responsible for proper outgrowth of the neurites. The 
adhesive properties of the AChE domain were studied using Drosophila cells. Chimeras in 
which the AChE homologous domain of neurotactin was replaced with the Drosophila- or 
Torpedo-AChE were generated. These chimeras retained the adhesive properties, whereas 
AChE alone showed no cell adhesion property (Darboux et al., 1996). However, AChE lacks 
a transmembrane domain and thus cannot send signals into the cell. It was therefore 
proposed that soluble AChE might compete with the structural homologues (e.g. Neuroligin-
1) and in this way send signals into the cell (Grifman et al., 1998). Bigbee and co-workers 
could provide a direct evidence for an adhesive function of AChE using two different cell 
(neuroblastoma)-substratum adhesion assays (Sharma et al., 2001). It has been postulated 
that the adhesion site on the AChE molecule might comprise regions around the peripheral 
anionic site (Johnson and Moore, 2000). Moreover, recent discoveries showed that the 
readthrough form of AChE, which accumulates in the neurons under stress conditions, 
interacts intraneuronally with the RACK1 and PCKβII (Birikh et al., 2003).  
Novel functions in physiology – activation of dopamine neurons. AChE is 
secreted in various areas of the brain including hypothalamus, striatum, hippocampus, 
cerebellum and the substantia nigra (review in Layer and Willbold, 1995). The cerebellar 
cortex is a region with low cholinergic transmission; therefore here one has to search for 
non-classical roles of AChE. The enzyme is released from dendrites of dopaminergic 
neurons in mammalian substantia nigra (Llinas and Greenfield, 1987). Purified AChE 
enhanced dopamine release from midbrain dopamine neuron. This prompted the Greenfield 
group to hypothesize that AChE acts as a neuroactive drug modulating catecholaminergic 
systems (Greenfield, 1984 a, b). 
Amyloid fibre assembly. AChE promotes amyloid fibre assembly (Inestrosa et al., 
1996). This activity was blocked by peripheral-site inhibitors (propidium), but not by the 
active site inhibitor edrophonium, identifying this activity as a non-classical function. 
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1.3. Binding partners for AChE – an overview 
 
The focus of this thesis was on non-classical, adhesive functions of the enzyme. The 
actions of AChE on differentiation and proliferation summarized above have been 
demonstrated in so many experimental systems and laboratories that they now must be 
considered firmly established functions of the protein. The adhesive functions of AChE 
involve additional proteins, since the enzyme does not function as a homologous cell 
adhesion protein. 
AChE as a heterophilic cell adhesion molecule. The core domain of AChE is 
homologous with non-catalytic proteins that have well-defined cell-cell adhesion roles: 
thyroglobulin and neuroligins in mammals, and gliotactin, glutactin and neurotactins in 
Drosophila. We first proposed that AChE has the same or similar binding partners as those 
demonstrated for its homologues. 
Neurexin-1β. Neuroligins are transmembrane proteins expressed in the CNS and 
localized post-synaptically (Song et al., 1999). The neuroligins form a family of cell adhesion 
proteins encoded by at least three genes. Their extracellular domain possesses ~ 35% 
homology with AChE. All three known neuroligins bind neurexin-1β, a pre-synaptic 
transmembrane protein with a large extracellular domain (Ichtchenko et al., 1996). 
Neurexin-1β is a member of a large family of neuronal proteins, composed of at least three 
genes (neurexins 1 through 3) driven by two promoters (α and β), resulting in the expression 
of at least six neurexin forms. Alternative mRNA splicing confers additional complexity to the 
possible gene products (Ichtchenko et al., 1996). The existence of thousands of neurexin 
isoforms makes them good candidates for cell-cell adhesion molecules. Intracellularly, the 
neurexins bind to CASK (CaM kinase), PSD95 and synaptotagmin (Missler and Südhof, 
1998). The neurexin-1β & neuroligin-1 couple was shown to promote synaptogenesis 
(Scheiffele et al., 2000) and mediate recognition processes between neurons by forming 
heterologous cell contacts at synaptic connections.  
Overexpressing human AChE in mice suppressed neurexin-1β production in 
embryonic mouse motoneurons (Andres et al., 1997). We therefore considered the 
possibility that AChE might compete with neuroligin-1 for binding to proteins of the neurexin 
family and that there is a cross-talk between AChE and neurexin during development. To 
provide a foundation for this hypothesis first the expression pattern of neurexin-1β in the 
retina was examined and compared with AChE. 
The developing retina was used for the neurexin-1β expression studies. The first 
reason was related to the fact that in the retina only few amacrine cells are cholinergically 
innervated. On the other hand, AChE is expressed very early in post-mitotic neurons and a 
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large population of cells expresses AChE during and after the development. This speaks for 
a predominantly non-classical function of the enzyme in the retina. The second reason was 
the retina’s highly organized laminar structure of alternating cell bodies (nuclear layers) and 
synaptic connections (plexiform) layers. 
Laminin-1. Neurexin-1β shows three-dimensional similarity to laminins and some 
lectins in spite of low (10-15%) sequence homology (see Figure 3). Laminin-1 is a part of 
the basement membrane and thus ideally placed as a potential ligand for AChE in the 
developing nervous system.  
The characterization of laminins started in 1979 with the observation that the 
Engelbreth-Holm-Swarm (EHS) tumor presents a non-collagenic component in the 
extracellular matrix. This component was a glycoprotein, named laminin (Timpl et al., 1979). 
Laminin is the major non-collagenous component of basement membranes and is able to 
polymerize into a network that is cross-linked with type IV collagen by the single-chain 
protein entactin/nidogen (Yurchenco and O’Rear, 1994). 
 
 
Figure 3. Comparison of the neurexin-1 extracellular domain and laminin-1. 
(Hohenester et al., 1999) 
 
The laminin molecule is a heterotrimer of three non-identical chains, called α-, β- and 
γ-chains, according to the new nomenclature (Burgeson et al., 1994). The three chains are 
members of a multigene family, and so far 5 α (α1-α5), 3 β (β1-β3) and 3 γ-chains (γ1-γ3) 
have been identified in vertebrates. All laminin chains are multidomain glycoproteins (Figure 
4) that contain a 570–600-amino acid α-helical region that forms a triple-stranded coiled-coil 
with the other two chains (Engvall and Wewer, 1996). The N-terminal regions of the chains 
are heterogeneous, consisting of alternating globular and cysteine-rich domains of varying 
size and number. The globular domains are known to be the sites of interaction with 
receptors and other ligands (Belkin und Stepp, 2000; Andac et al., 1999; Nielsen et al., 
2000; Talts et al., 1999). The α-chains contain an additional C-terminal globular domain of 
approximately 100 kDa (see Figure 4). 
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Figure 4. Laminin structure. From the Molecular Cell Biology, 4th edition by Harvey Lodish, 
Arnold Berk, S. Lawrence Zipursky, Paul Matsudaira, David Baltimore, and James Darnell. 
 
Laminin has many and varied functions that are mediated by binding to various 
components of the basement membrane (Aumailley and Krieg, 1996; Aumailley and 
Rousselle, 1999; Colognato et al., 2000). As a cell attachment factor it promotes neurite 
outgrowth and influences neuron migration, growth, morphology, and adhesion, all functions 
important in tissue repair. A number of laminin-binding cellular proteins have been 
characterized, including a variety of cell surface integrins that mediate the interactions of 
cells with laminin (DiPersio et al., 1997; Belkin and Stepp, 2000). It was also shown that 
biotinylated human AChE binds to mouse laminin-1 and collagen IV by an electrostatic 
mechanism (Johnson and Moore, 2003). This in vitro study together with the fact that 
laminin-1 is like AChE very early expressed during embryonic development (Dziadek and 
Timpl, 1985) provide a basis for interaction studies using other approaches (e.g. yeast two-
hybrid, co-immunoprecipitation, surface plasmon resonance). However, more experimental 
data are necessary and a part of this thesis presents experiments that support the 
hypothesis and bring more insight into the nature of this interaction. In fact, interaction 
between AChE and laminin-1 could well be one of the missing links between AChE and 
other neuronal cell adhesion molecules like integrins. Laminins are known to interact with 
integrins, a class of receptors coupling proteins from the extracellular matrix with the 
cytoskeleton, thus linking cell-cell adhesion with cell signaling. 
RACK1 and PKCβII. Another important point concerning AChE ligands is the fact 
that the enzyme is localized extracellularly, soluble or bound to the cell membranes. 
Therefore, one has to look for extracellular binding partners. However, the normally rare 
AChE splice variant AChE read-through (AChE-R) is overproduced under stress conditions 
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in mice (Meshorer et al., 2002), and reduces the stress-induced ACh levels at extracellular 
sites (Kaufer et al., 1998). Moreover, AChE-R also accumulates in neuronal cell bodies 
where it interacts with the scaffolding protein RACK1 and through it, with its target, protein 
kinase C-βII (PKCβII) (Birikh et al., 2003). RACK1 belongs to the family of 
tryptophan/aspartate proteins, which can simultaneously bind different proteins, e.g. β-
integrin, src-kinase or β-adrenergic receptor. 
 
1.4. The Yeast Two-Hybrid System – a genetic approach used to find 
AChE ligands 
 
A yeast two-hybrid screen was chosen to study possible AChE protein – protein 
interactions. The yeast two-hybrid system was introduced to the scientific community by 
Fields and Song in 1989. Most yeast genes are preceded by cis elements called upstream 
activating sequences (UASs), which are recognized by transcription activators. Eukaryotic 
transcription activator proteins are composed of at least two domains that can operate 
independently. The DNA binding domain (BD) binds to specific DNA sequences and the 
transcription activation domain (AD) initiates transcription by contacting proteins associated 
with the promoter. Two-hybrid systems make use of the fact that these two domains can be 
expressed separately, and then forced together non-covalently to form a fully functional 
transcription activator.  
 
Figure 5. The principle of the yeast two-hybrid system. The interaction between AChE and 
a library protein reconstitutes the GAL4-transcription activator, which leads to the expression of the 
reporter gene. 
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Introduction 12
If the binding domain is fused to ‘AChE’ to create a ‘BD-AChE’ hybrid, and the 
activation domain is fused to protein ‘X’ from a cDNA library to create an ‘AD-X’ hybrid, then 
an interaction between AChE and X from the library creates a functional activator which can 
stimulate transcription of an easily detectable reporter gene. The BD-AChE hybrid is 
referred to as the ‘bait’ and the AD-X hybrid is called the ‘prey’. In this case, the binding 
domain of LexA binds to AD of GAL4 to activate transcription of an E. coli lacZ reporter 
gene that is integrated into the yeast genome. 
The yeast two-hybrid system was used because it has some clear advantages over 
classical biochemical and genetic approaches. First of all it is an in vivo technique that uses 
the yeast host cell as a system. This yeast system brings the higher eukaryotic reality closer 
than most in vitro approaches or techniques based on bacterial expression. Appealing 
features of this system are the minimal requirements to initiate a screening. Only the cDNA, 
full-length or even partial of the gene of interest is needed, in contrast to sometimes high 
quantities of purified proteins or good quality antibodies needed in classical biochemical 
approaches. One of the most appealing features of the yeast two-hybrid system is that the 
identification of an interacting protein implies that at the same time the corresponding gene 
is cloned. 
 
1.5. Aims and objectives of the study 
 
The non-classical functions of AChE are intriguing phenomena with important 
implications aside from the hydrolysis of ACh. The mechanism(s) by which AChE signals its 
morphogenic functions, however, is a subject of speculation. This gave us the opportunity 
for planning of new research directions. We hypothesized that AChE is able to send signals 
into the cell by binding to another protein, that should have the following requisites: be 
expressed in the same tissues and at the same developmental stages as AChE, have both 
an extracellular and an intracellular domain connected through one or more transmembrane 
domains, and possibly be able to initiate an intracellular signaling cascade. Following this 
hypothesis, we searched for AChE ligands in the central nervous system.  
Three approaches have been chosen for this. We first attempted to show that AChE 
binds to neurexin-1β, a ligand for a highly AChE homologous protein – neuroligin-1. This 
binding would explain the synaptogenesis related functions of AChE. Localization studies 
for neurexin-1β were also an objective, since there is little known about the expression 
patterns of this molecule. A second approach was to use surface plasmon resonance and 
mass spectrometry for finding an AChE unknown partner. Thirdly, a genetic approach (yeast 
two-hybrid system) was favored to the plasmon resonance and used to screen for unknown 
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AChE binding partners, considering that yeast systems are generally intensively optimized. 
The potential AChE binding partners revealed by screening would bring answers to some 
old questions and at the same time open new questions for the field of cholinesterase 
research.  
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2. Materials and methods 
 
2.1. Materials 
 
2.1.1. Instruments 
 
Autoclave Webeco, Bad Schwartau 
Balances Sartorius, Göttingen 
Cell culture hood Heraeus, Hanau 
Centrifuges Sigma, J2-21, Beckman, USA 
Eppendorfcentrifuge A14, Jouan 
Cryostat Microm, Walldorf 
Electrophoresis chamber (for DNA) Peq-lab, Erlangen 
Electrophoresis chamber (for proteins) Bio-Rad, München 
Electrophoresis power supply Bio-Rad, Consort E321, München, Biometra 
Powerpack P25 
Electroporator Bio-Rad, Hercules, California, USA 
Freezers Queue Systems, USA 
Heat block Janke&Kunkel 
Incubators, for bacterial culture Heraeus, Hanau 
Incubator, for COS, ES cell culture Nuaire, Sarstedt 
Incubator shaker New Brunswick Scientific, Edison, USA; 
WTC 
Magnetic stirring plates Itec, Staufen 
Microwave oven Bosch, Stuttgart 
Multipipette Brand  
Microscopes Axiophot light microscope with fluorescence, 
Carl Zeiss, Jena 
Olympus SC 35 
pH meter WTW Wissenschaftlich Technische 
Werkstätten, Weilheim 
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Pipettes Eppendorf, Hamburg 
Pipetting device Hirschmann, Eberstadt 
Refrigerators Privileg, Liebherr, Biberach an der Riß 
Rotators Heidolph Reax 3 
Shakers GFL, Burgwedel 
SLT-ELISA reader Spectra, Crailsheim 
Sonicator Bandelin Electronic, Berlin 
Spectrophotometer Perkin Elmer, Langen 
Sterilization oven Memmert, Schwabach 
Thermocycler Biometra, Göttingen 
Ultracentrifuge Beckman, Krefeld 
UV documentation, N-90E Bender, Wiesloch 
Vacuum concentrator, Speedvac Bachofer, Reutlingen 
Vortex Heidolph, GFL, Burgwedel 
Waterbaths Memmert, Schwabach 
 
2.1.2. General chemicals 
 
Chemicals were of highest purity (for molecular biology or pro analysi). 
Agarose Peqlab, Erlangen 
Alkaline phophatase Roche, Mannheim 
Ampicilline, sodium salt Sigma, Deisenhofen 
APS Roth, Karlsruhe 
ATC Serva, Heidelberg 
ATP Sigma, Deisenhofen 
Bromophenol blue VWR, Darmstadt 
BSA Sigma, Deisenhofen 
CaCl2 VWR, Darmstadt 
DAB Sigma, Deisenhofen 
Dianisidine Fulka, Bucsh 
Diethanolamine Sigma, Deisenhofen 
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DAPI Boehringer, Mannheim 
DMF VWR, Darmstadt 
DMSO Sigma, Deisenhofen 
DNA standard Roth, Karlsruhe 
DTNB( 5,5’-Dithio-bis-2-nitro-benzoacid) VWR, Darmstadt 
EDTA·Na2·2H2O Sigma, Deisenhofen 
Ethanol Roth, Karlsruhe 
Eukobrom Tetenal developer Hirrlinger, Stuttgart 
Ethidium bromide Roth, Karlsruhe 
Formaline 37% VWR, Darmstadt 
Formamide Sigma Deisenhofen 
Gelatin Sigma, Deisenhofen 
Glucose VWR, Darmstadt 
Glycerol VWR, Darmstadt 
H2O2 VWR, Darmstadt 
HCl VWR, Darmstadt 
HEPES, sodium salt VWR, Darmstadt 
Hexanucleotide mix Roth, Karlsruhe 
Iso-OMPA Sigma, Deisenhofen 
Isopropanol VWR, Darmstadt 
Kanamycine sulfate Fluka, München 
KCl VWR, Darmstadt 
Methanol VWR, Darmstadt 
Milk powder Roth, Karlsruhe 
ß-Mercaptoethanol VWR, Darmstadt 
MOPS (3-(N-Morpholino)propanesulfonic 
acid)
Roth, Karlsruhe 
NaCl VWR, Darmstadt 
NaCH3COO VWR, Darmstadt 
Na2HPO4 VWR, Darmstadt 
PEG 3500 Sigma, Deisenhofen 
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Phenol VWR, Darmstadt 
Phenol/Chloroform/Isoamyl alcohol Roth, Karlsruhe 
Ponceau S Sigma, Taufkirchen 
Protease inhibitor cocktail Sigma, Taufkirchen 
Protein standards Sigma, Taufkirchen 
Restriction endonucleases, buffers New England Biolabs,  
Salmon sperm DNA Sigma, Deisenhofen 
SDS VWR, Darmstadt 
Sucrose VWR, Darmstadt 
Taq DNA polymerase Roche, Mannheim 
T4 DNA ligase, buffer Invitrogen, Karlsruhe 
TEMED Roth, Karlsruhe 
Thiamine Fluka, München 
Tissue freezing medium Miles Scientific, USA 
Tris Sigma, Deisenhofen 
Tri-sodium citrate·2H2O VWR, Darmstadt 
TritonX100 Sigma, Deisenhofen 
Tryptone-peptone Difco, UK 
X-gal Fluka, München 
 
2.1.3. Chemicals for cell culture 
 
DMEM powder Gibco, Eggenstein 
PBS Gibco, Eggenstein 
FCS Gibco, Eggenstein 
G418 sulfate Sigma, Deisenhofen 
L-Glutamine Seromed, Berlin 
Penicillin/Streptomycin Cambrex, USA 
Trypsin/EDTA Gibco, Eggenstein 
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2.1.4. Kits 
 
Plasmid Maxi Kit Qiagen, Hilden 
Nucleospin Extract Machery-Nagel, Düren 
Wizard Miniprep Kit Promega. Mannheim 
Immunoprecipitation starter kit Amersham, Heidelberg 
ECL (enhanced chemiluminescence) 
Western Blotting Analysis System 
Amersham, Heidelberg 
Silver Stain Plus Bio-Rad, München 
 
2.1.5. Consumables 
 
Blotting paper Schleicher & Schuell, Dassel; Whatman, 
Maidstone, UK 
Cell culture plastic equipment Greiner, Frickenhausen 
Concentrators Millipore, Bedford, Massachusetts, USA 
Electroporation cuvettes Bio-Rad, Hercules, California, USA 
Falcon tubes (14 ml) Greiner, Frickenhausen 
Films Röntgen films, Sigma, Deisenhofen 
Polaroid Films, Amersham 
Filters Schleicher & Schuell, Dassel 
Glass coverslips Menzel-Gläser, Braunschweig 
Glass slides Menzel-Gläser, Braunschweig 
Hybond-N nylon membranes Amersham Pharmacia Biotech, Heidelberg 
Microcentrifuge tubes Greiner, Frickenhausen 
Nitrocellulose membranes Whatman Biometra, Göttingen 
Parafilm Neolab, Heidelberg 
Pasteur pipettes Volac, UK 
Pipettes (1 ml, 5 ml, 10 ml, 25 ml) VWR, Darmstadt 
Pipette tips AHN Biotechnologie, Nordhausen 
Plastic tubes for bacterial centrifugations AHN Biotechnologie, Nordhausen 
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Plastic tubes, sterile (15 ml, 50 ml) Greiner, Frickenhausen 
Plates, for bacterial culture Greiner, Frickenhausen 
PCR tubes Sarstedt, Nümbrecht 
Safe-lock microcentrifuge tubes Eppendorf, Hamburg 
SDS-PAGE gel loading syringe Hamilton, Switzerland 
Spectrophotometry cuvettes  
 
2.1.6. Enzymes 
 
Pfu DNA polymerase Promega, Mannheim 
Restriction endonucleases New England Biolabs, USA 
Ribonuclease Roche, Mannheim 
Taq DNA polymerase Eppendorf, Hamburg 
T4 DNA-ligase Invitrogen, Karlsruhe 
 
2.1.7. Media for bacterial culture 
 
LB agar 
32 g of LB agar powder were dissolved in 1 L dH2O and autoclaved. Complete 
dissolution was achieved only during autoclaving. The solution was cooled to ~ 50°C and 
antibiotics were added optionally for antibiotic-resistance selection. The solution was poured 
onto 85 mm or 150 mm plates (~ 40 ml or ~ 100 ml per plate, respectively), and the plates 
were shortly flamed on a Bunsen burner, to break any air bubbles. The plates were let at RT 
o/n to allow LB agar to solidify and dry, and kept inverted at 4°C. 
Composition: 1% peptone, 0.5% yeast extract, 0.5% NaCl, 1.2% agar. 
 
LB medium 
20 g of LB broth base were dissolved in 1 L dH2O, autoclaved and stored at RT. For 
antibiotic resistance selection, the antibiotics were added before use. 
Composition: 1% peptone, 0.5% yeast extract, 0.5% NaCl. 
 
SOC medium 
High quality medium, used for special applications. Obtained ready to use.  
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Composition: 2% tryptone, 0.5% yeast extract, 10 mM NaCl, 2.5 mM KCl, 10 mM 
MgCl2, 10 mM MgSO4, 20 mM glucose. 
 
M9 synthetic minimal medium 
Per liter: 
5XM9 salts 200 ml 
1M MgSO4 2 ml 
0.1 M CaCl2 2 ml 
20% Glucose  20 ml 
50 mg/ml Ampicilline  1 ml 
1 M Thiamine 1 ml 
 
5XM9 salts is made by dissolving the following salts in de-ionized H2O to a final 
volume of one liter: 
 
Na2HPO4  7H2O 64g 
KH2PO4 15g 
NaCl 2.5g 
NH4Cl 5g 
 
Antibiotic concentrations: 
Ampicilline 50 µg/ml, stored as 1000x stock in dH2O, at -20°C. 
Kanamycine 30 µg/ml, stored as 1000x stock in dH2O, at -20°C. 
 
2.1.8. Media for yeast culture (Gietz, 1992) 
 
YPD-Medium  
 
20 g/L Peptone 
10 g/L Yeast extract 
2% (w/v) Glucose 
30 mg/L Adenine hemisulfate 
18 g/L Agar (YPD-Agar) pH 5.8 
DO-Medium 
 
6.7 g/L yeast nitrogen base without amino 
acids 
2% Glucose 
4 g/L Synthetic Drop out mix (10X) 
18 g/L Agar (for SD-Agar) pH 5.6 
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Synthetic Complete drop-out Medium 
Mix (SC drop-out) 10X 
 
2.0 g Adenine hemisulfate*  
2.0 g Arginine HCl  
2.0 g Histidine HCl*  
2.0 g Isoleucine  
2.0 g Leucine*  
2.0 g Lysine HCl  
2.0 g Methionine  
3.0 g Phenylalanine  
6.0 g Homoserine  
3.0 g Tryptophan*  
2.0 g Tyrosine  
1.2 g Uracil*  
9.0 g Valine  
 
The appropriate amino acid(s) (marked with *) were omitted from the SC drop-out in 
order to prepare DO-His, DO-Leu, DO-Trp, DO- Trp/Leu, and DO-Trp/Leu/His. All the amino 
acids were purchased from VWR, Darmstadt. 
 
2.1.9. Media for cell culture 
 
Dulbecco’s modified Eagle DMEM (Gibco), containing: 
10% fetal calf serum, FCS 
1% Glutamine 
0.1% Penicillin/ Streptomycin. 
 
DMEM-minimal medium (used for transfections) 
2%FCS 
1% Glutamine 
0.1% Penicillin/ Streptomycin. 
 
2.1.10. Bacterial strains 
 
Escherichia coli XL1-Blue (Bullock et al., 1987). 
 
Escherichia coli DH5 α (Hanahan, 1983). 
 
Escherichia coli HB101 (Bolivar und Beckmann, 1979). 
 
2.1.11. Yeast strains 
 
The yeast two-hybrid screen was carried out using reporter strain L40 (Vojtek et al., 
1993). Genotype of Strain L40: 
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MATa his3-delta200 trp1-901 leu2-3,112 ade2 lys2-801am LYS2::(lexAop)4-HIS3 
URA3::(lexAop)8-lacZ GAL4. 
 
2.1.12. Eukaryotic cell lines 
 
HEK 293 - human embryonic kidney cells (used for transfections and expression of 
AChE). American Type Culture Collection, Manassas, Virginia, USA. 
 
2.1.13. Yeast two-hybrid cDNA library 
 
Mouse brain MATCHMAKER cDNA library, cloning vector pACT2, (Clontech, 
Heidelberg, Germany). 
 
2.1.14. cDNA clones 
 
Acetylcholinesterase (AChE) cDNA clone 
(exons 2, 3, 4, and partially 6) 
kindly provided by Prof P. Taylor , UCSD, 
USA, (Marchot et al., 1996) cloned in 
pCDNA3 (Invitrogen) 
Neurexin I chicken in pBluescript kindly provided by Uwe Ernsberger, 
University of Heidelberg (Patzke and 
Ernsberger, 2000) 
Neurofilament M chicken generous gift of Uwe Ernsberger, University 
of Heidelberg (Stanke et al., 1999) 
pLamin cDNA clone (aa 67-230) in pAD-
Gal4 
generous gift of Prof. Holstein, TU 
Darmstadt 
pCMS-EGFP Clontech, Heidelberg 
p53, in pBD-p53 generous gift of Prof. Holstein, TU 
Darmstadt 
RalAV23, cloned in pBTM116 kindly provided by Jaques Camonis, PhD, 
Institut Pasteur, Paris, France (Jullien-Flores 
et al., 1995) 
RLIP (RRall interacting protein) in pGADGH kindly provided by Jaques Camonis, PhD, 
Institut Pasteur, Paris, France (Jullien-Flores 
et al., 1995) 
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Synaptotagmin I chicken in pGEM7 kindly provided by Uwe Ernsberger, 
University of Heidelberg (Campagna et al., 
1997) 
Tyrosine hydroxylase chicken in pBluescript kindly provided by Uwe Ernsberger, 
Univesity of Heidelberg (Ernsberger et al., 
1995) 
 
2.1.15. Vectors and plasmids 
 
pVJL 10, pVJL 11, pBTM 116, the yeast two-hybrid vectors containing the LexA binding 
domain, were a generous gift of Jaques Camonis, Institut Pasteur, Paris, France. 
pGEX-2T kindly provided by Prof Pfeifer, Institute for Microbiology, TU Darmstadt. 
pBluescript, Promega. 
 
2.1.16. Primary antibodies 
 
Goat anti AChE mouse, polyclonal, 200 
µg/ml 
Santa Cruz Technologies, USA 
Mouse anti-AChE chicken, monoclonal, 
clone 3D10, 2mg/ml 
Tsim et al., 1988 
Rabbit anti-Laminin mammalian species, 
polyclonal, 1:100 
Sigma, Deisenhofen 
Anti DIG Fab fragments Roche, Mannheim 
Rat anti-Laminin beta1 mouse, monoclonal Chemicon International, Temecula, 
California, USA 
 
2.1.17. Secondary antibodies 
 
Donkey anti rabbit, DFAT conjugated Dianova, Hamburg 
Donkey anti rat, biotin conjugated Dianova, Hamburg 
Goat anti mouse, Cy3 conjugated  Dianova, Hamburg 
Goat anti rabbit, POX conjugated Sigma, Deisenhofen 
Goat anti rat, POX conjugated Sigma, Deisenhofen 
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Rabbit anti goat, POX conjugated  Sigma, Deisenhofen 
Rabbit anti goat, Cy3 conjugated Dianova, Hamburg 
Rabbit anti mouse, Cy3 conjugated Dianova, Hamburg 
 
2.1.18. Synthetic oligonucleotides 
 
 Synthetic oligonucleotides were used as PCR primers, as primers for sequencing or 
for DNA. They were synthesized by Carl Roth GmbH, Karlsruhe. 
 
EcoR1 AChE (left) 5´ ATGAATTCGGCCGGGAAGACCCGCAGC 3´ 
Pst1 2060 AChE (right) 5´ TGGGACCCCGTAAACCAG 3´ 
Sph1 1790 AChE (right) 5´ CTCTGGAGGACAGCCCTG 3´ 
AChE 1430 (right) 5´ AGCAGGTCTGGGGTATGG 3´ 
AChE BamH1 insert orientation (left) 5´ AAGATCCTCTCCTCCGTGGT 3´ 
AChE BamH1 insert orientation (right) 5´ ATGCCATGAGTGCAGTGGTA 3´ 
AChE P2 EcoR1 (left) 5´ ATGGAATTCGTGGGCATGCACATA 3´ 
AChE P2 Bam H1 (right) 5´ CTCTCCTCCGTGGTGTAGTC 3´ 
Gal4AD sequencing primer  5´ ATACCACTACAATGGAT 3´ 
pACT2 insert screen (left) 5´ GCGTATAACGCGTTTGGAAT 3´ 
pACT2 insert screen (right) 5´ TTGCGGGGTTTTTCAGTATC 3´ 
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2.2. Methods 
 
2.2.1. Nucleic acid analysis 
 
2.2.1.1. Competent cell preparation 
 
In order to achieve high amplification of DNA, plasmid DNA was inserted into E. coli 
(strain XL1-Blue MRF´, DHα5 or strain HB101) by chemical transformation or 
electroporation. There are two main methods for preparation of competent bacterial cells for 
transformation, the calcium chloride and the electroporation method.  
 
2.2.1.1.1. Preparation of chemo-competent bacteria 
 
For the calcium chloride method, a glycerol cell culture stock of the respective E. coli 
strain was thawed and added to 50 ml of LB liquid media. This culture then was pre-
incubated at 37°C for 1 hour in a water bath without shaking, transferred to an incubator-
shaker, and incubated further for 2-3 hours at 37°C and 225 rpm. The cells were pelleted by 
centrifugation at 3000 rpm for 8 minutes at 4°C in a Beckman or 6000 rpm in a RC5-B 
(DuPont), resuspended in one half volume (20 ml) cold 50 mM calcium chloride solution, 
and incubated on ice for 20 minutes. After another centrifugation step, the resulting cell 
pellet was resuspended in one tenth volume (4 ml) of cold, sterile 50 mM calcium chloride to 
yield the final competent cell suspension. Competent cells were stored at 4°C, for up to 
several days or glycerol can be added to a final concentration of 17%, so that the cells can 
be placed at -70°C and stored indefinitely. 
 
2.2.1.1.2. Transformation of chemo-competent bacteria (Hanahan, 1983) 
 
In order to use competent cells for transformation, 100 µl aliquots were removed from 
freezer and thawed for a few minutes at RT. Plasmid DNA was added (~10 ng) and 
incubated with the cells for 15 minutes as in the standard transformation procedure. This 
time period allows the plasmid DNA to attach to the cell membrane. The bacteria were heat 
shocked at 42°C for 2 minutes (during which the plasmid DNA enters the cell), cooled 
briefly, and incubated for 1 hour at 37°C in one ml LB before spreading on selective plates.  
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2.2.1.1.3. Preparation of electro-competent bacteria 
 
50 ml of LB liquid bacterial growing medium was inoculated with a single colony from 
an LB agar plate. Bacterial cells were grown at 37°C, o/n, shaking at 225 rpm. 1 L of LB 
medium was inoculated with 10 ml of the above culture. Cells were grown at 37°C for 3-5 h, 
until they reached an OD600 of ~ 0.6-0.7. Cells were centrifuged at 1500 g, 4°C, for 15 min 
and resuspended in 1 L of ice-cold 10% glycerol. The centrifugation and resuspension steps 
were repeated two times with 500 ml and 250 ml of 10% glycerol and cells were finally 
resuspended in 4 ml of 10% glycerol. Cells were shock-frozen in liquid nitrogen in 40 µl 
aliquots and stored at -80°C. 
 
2.2.1.1.4. Electro-transformation (electroporation) of bacteria with plasmid DNA 
 
2 µl of plasmid DNA (ligation mixture, diluted 1:4 with TE or yeast plasmid 
preparation, diluted with TE) were mixed with 40 µl of electro-competent bacteria (which 
was thawed on ice) and kept on ice for 1-5 min. The mixture was transferred to an ice cold 
electroporation cuvette and pulsed at 2.5 kV in an E. coli pulser (Bio-Rad). In order to allow 
bacteria to recover, they were transferred to 1 ml SOB medium and incubated at 37°C for 1 
hour, shaking at 250 rpm. For mini DNA preparations, bacteria were plated on 85 mm LB 
agar plates, containing the appropriate antibiotic, and grown at 37°C o/n. For maxi DNA 
preparation, 4 ml of LB medium, containing the appropriate antibiotic were added to the 
transformed bacteria and incubation was continued at 37°C for 4 h. 1 ml of the culture was 
used to inoculate 500 ml of LB medium with the appropriate antibiotic and cells were grown 
at 37°C o/n. 
 
2.2.1.2. Plasmid DNA preparations 
 
2.2.1.2.1. DNA mini-prep 
 
5 ml (mini) cultures were inoculated with single colonies from LB agar plates and 
grown o/n. DNA was extracted and purified, using the Wizard Plus Miniprep Kit (Promega), 
and stored in 10 mM Tris-HCl, pH 8.5 at 4°C. Purification of plasmid DNA with this kit is 
based on an alkaline lysis procedure, followed by adsorption of plasmid DNA onto a silica-
gel membrane. Purified DNA was analyzed with restriction enzymes and, optionally, with 
DNA sequencing. 
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For cloning and subcloning a Birnboim (1983) protocol was used. Starting with 2 ml 
o/n cultures (LB, other E. coli broths), 1.5 ml were poured into 1.5 ml microfuge tubes and 
centrifuged 1 min in a microfuge (bacteria were pelleted). After carefully aspirating off the 
medium, 150 µl of Solution I (isotonic solution) were added and the pellet was resuspended 
by vortexing. 300 µl of Solution II (lysis solution) were added and mixed completely by 
inverting the microfuge tube. The cells should lyse and turn somewhat clear and viscous. 
After ~3 min incubation on ice, addition of 225 µl Solution III, and mixing by inversion, a 
white clot of DNA/protein/SDS should form. The mixture was incubated on ice 10-30 min 
and centrifuged for 15 min at 12000g in a microfuge. The supernatant (~400 µl) was 
transferred into a fresh 1.5 ml microfuge tube and the DNA was precipitated with 1 ml 95% 
ethanol. After centrifugation in a microfuge for ~15 min at max speed, the ethanol was 
decanted and the pellet dried in speed vac or air dry. The pellet was resuspended in 50 µl 
water or TE (the resuspension volume was dependent on copy number of plasmid). The 
plasmid DNA was now ready for restriction digestion, PCR, subcloning, etc. These DNA 
preparations contain RNA; therefore in case of complications a standard RNase treatment 
may be applied. Further cleanup can be accomplished with phenol/chloroform extractions 
but for routine screening and subcloning this was often not necessary. 
 Solution I Solution II Solution III 
 5 mM sucrose 
 10 mM EDTA  
 25 mM Tris, pH 8.0 
 0.2 N NaOH  
 1% (w/v) SDS 
 3 M sodium acetate, pH 4.8 
 
2.2.1.2.2. DNA maxiprep 
 
For most cloned constructs, a higher and better purified amount of DNA was 
prepared by the maxiprep procedure. DNA was extracted and purified using the Qiagen 
Plasmid Maxi Kit, and stored in TE (see below) at -20°C. Purification of plasmid DNA with 
this kit is based on an alkaline lysis procedure, and the binding of plasmid DNA to an anion-
exchange resin. The composition of purified DNA was confirmed with restriction analysis.  
TE buffer - 10 mM Tris, 1 mM EDTA·Na2⊕2H2O, pH 8.0.  
DNA is more stable in slightly alkaline conditions; EDTA stabilizes DNA by forming a 
complex with Mg++, which is required for DNA hydrolysis by DNases. 
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2.2.1.3. Restriction enzyme analysis of DNA 
 
In order to check the composition of purified nucleic acids, DNA was digested with 
restriction endonucleases. Digestions were carried out for 1 hour to o/n, in 10 µl reaction 
volume; in the optimal buffer for each endonuclease (suggested and provided as 10x 
concentrations by New England Biolabs or Promega).The digestion temperature was 37°C 
for most endonucleases, although with some enzymes an o/n cut was made at 4°C. In some 
cases, double enzyme digestions were also carried out. The buffers used were determined 
by a compatibility table, provided by Promega. In cases where the optimal temperature of 
the two enzymes was different, the digestion was performed first at the lower temperature 
(usually 37°C) and then at the higher temperature. 
 
2.2.1.4. Agarose gel electrophoresis 
 
During agarose gel electrophoresis, DNA fragments are separated according to their 
size, the smaller a fragment is, the faster it migrates. The size of a fragment is estimated by 
the comparison to the sizes of the bands of a DNA molecular weight marker. Agarose, in a 
concentration of 0.7-1.5%, was dissolved in 1x TAE in a microwave oven. The solution was 
cooled to ~ 60°C and ethidium bromide was added, at final concentration 1 µg/ml. The 
solution was poured into a gel chamber with a well separator and let to solidify at RT. The 
concentration of the gel reflects the area of DNA size where separation is required to be 
optimal, large fragments (> 3 kb) separate better in low concentration gels, and small 
fragments in high concentration gels. DNA samples were mixed with 1/10 volume of 10x 
loading buffer (see below) and loaded into the wells of the gel. Gels were electrophoresed 
at 80-120 V for 30 min - 4 h in 1x TAE. The DNA bands, based on their binding to ethidium 
bromide, were visualized under UV light. 
Buffers: 
50x TAE: 2 M Tris, 50 mM EDTA·Na2⊕2H2O, 4% acetic acid, pH 8.5. 
10x loading buffer: 57% glycerol, 100 mM Tris pH 8.0, 10 mM EDTA·Na2⊕2H2O, ~ 0.001% 
bromophenol blue. 
 
2.2.1.5. Purification of DNA from preparative digestions 
 
DNA digestions for cloning purposes (preparative digestions) were carried out o/n, in 
30 µl reaction volume. Digested DNA was either run on an agarose gel to separate different 
fragments or used directly (usually vector digestions). DNA was purified from agarose gels 
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either using the Nucleo Spin Extraction Kit (Macherey-Nagel), according to manufacturer’s 
protocol, or by glass wool: phenol/chloroform extraction. When the second method was 
followed, the DNA band was collected from the gel, cut into small pieces with a scalpel and 
introduced into a 500 µl microfuge tube. The tube has a small hole at the bottom and 1/5th 
was filled with glass wool to prevent the contamination of the DNA solution with agarose. 
The 500 µl microfuge tube was inserted into a 1.5 ml microfuge tube and the DNA was 
collected by centrifugation 10 min at 8000 rpm. The method is based on the property of 
DNA to be water soluble. The collected solution was further purified by phenol/chloroform 
extraction. 
 
2.2.1.6. Phenol/chloroform extraction and ethanol precipitation of DNA 
 
Phenol/chloroform is used to purify and concentrate DNA from different preparations. 
Such extraction is used to inactivate and remove enzymes that are used in one step of a 
cloning operation. The procedure takes advantage of the fact that protein removal is more 
efficient when two different organic solvents are used instead of one. Phenol denatures 
proteins very efficiently, but does not completely inhibit RNase activity, and acts as a 
solvent for RNA molecules; this is the reason for using mixture of 
phenol:chlorophorm:isoamylalcohol (25:24:1) (PCI). The DNA solution was transferred to a 
microfuge tube and an equal amount of PCI was added. The contents were mixed 
(vortexed) until an emulsion was formed and than centrifuged for 15 s at max speed on a 
microfuge at RT. The aqueous phase is formed as the upper phase, normally. With a pipette 
the upper phase was transferred to a new tube and the nucleic acids were recovered by 
precipitation with 2 volumes 100% ethanol and 1/10 volume of sodium acetate 3M and 
centrifugation for 30 min at 4°C and 12000 rpm.  
 
2.2.1.7. Ligation 
 
DNA ends of different or the same DNA fragment were ligated by incubation with T4 
DNA ligase at 12-15°C or 4°C o/n. Ligation is the formation of a covalent bond between a 5′ 
phosphate and a 3′ hydroxyl group. Ligation reaction mixture included 10 - 100 ng of vector 
DNA and 1-5 times more “insert” DNA, in molecular quantities. 
The amount of necessary insert was calculated with the following formula: 
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  Size of Insert (bp) x amount of Vector (10 to 100 ng) 
ng Insert = 
    Size of Vector (bp) 
 
The reaction was carried out in 10 µl volume, using 1 µl (4U) of T4 DNA ligase, in 1x 
ligation buffer (it was provided with the ligase and included the required ATP). 
 
2.2.1.8. Measurement of DNA concentration 
 
DNA concentration was estimated using agarose gel electrophoresis, by comparing 
the intensity of a small amount of purified DNA with that of 10 µl of 0.1 µg/µl DNA molecular 
weight marker (Roth). For more accurate quantitations, the OD at 260nm of a specific 
dilution (usually 1:20) of purified DNA was measured. The concentration of DNA was 
calculated according to the following formula:  
 
double-stranded DNA: 1.0 OD260 unit = 50 µg/ml  
or  
OD260 X dilution factor X DNA factor (50) = µg DNA / µl 
 
2.2.1.9. PCR (polymerase chain reaction) (Saiki et al., 1985) 
 
The Polymerase Chain Reaction enables the synthesis of specific DNA sequences 
using two oligonucleotides complement to the two DNA strands. The reaction requires a 
Thermocycler, to control the exact temperature for each of the different steps that 
characterize the PCR: melting, annealing, and amplification. The amplification reaction is 
carried out by the heat resistant polymerase named Taq DNA polymerase. This technique 
provides a high variety of application possibilities, outgoing from different types of 
templates, as DNA, RNA or cDNA. Thus, the PCR can be used to confirm the presence of a 
DNA fragment in a plasmid, the expression of certain gene (RT-PCR) or can be used to 
prepare DNA fragments for cloning. The PCR was used in this work to generate fragments 
for cloning and to check the presence and orientation of a specific insert in a vector. 
 
Standardized PCR protocol 
Reaction mix:  
DNA 10-100ng 
Materials and Methods 
 
31
PCR-buffer1x  
dNTPs 200µM 
MgCl2  between 1mM and 5mM 
Primer left 100pmol 
Primer right 100pmol 
Taq-polymerase 2.5U/ 50µl reaction volume 
H2O to a final volume of 50µl or 100µl 
 
Cycle parameters: 
94ºC 2 min 1 cycle 
94ºC 1 min 30 cycles 
60ºC 1 min (temperature depends on the Tm on the applied Primers) 
72ºC X min (time depends on the length of the fragment; 1kb/min) 
72ºC 5 min 1 cycle 
PCR buffer 10x: 500 mM KCl, 200 mM Tris-HCl, pH 8.6, 1% Triton X-100. 
 
2.2.1.10. Colony PCR (yeast) 
 
In order to check up the expression of different genes on a yeast colony, we 
employed PCR on yeast colonies, a fast and easy control method for expression studies. A 
bit of a colony was trashed into a PCR tube, 50 µl H2O were added, and the mixture was 
boiled for 10 min and centrifuged 5 min at 12000 rpm at RT. 1 to 5 µl were used for a 
regular PCR reaction. Reaction mix (see up) 
 
Cycle parameters 
95ºC 3min 
55°C 1min  2 cycles 
72°C 3min 
 
 
 
 
95ºC 3min  
55ºC 1min (temperature depends on the Tm of the applied Primers)   30 cycles
72ºC 3min 
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2.2.1.11. Sequencing of DNA 
 
Sequencing of DNA clones was performed automatically using oligonucleotides 
labeled with fluorescence (Automated Laser Fluorescence) and using the Applied 
Biosystems sequencing system (Pharmacia). The Sequencing process was performed by 
the Seqlab Laboratoires (Göttingen, Germany). 
 
2.2.2. Yeast-Two-Hybrid Screen (Fields and Song, 1989)  
 
Through the Yeast-Two-Hybrid-System is possible to identify protein-protein 
interactions in vivo. The Yeast-Two-Hybrid-System was used to identify in vivo interaction 
partners for AChE. The system is based on the properties of eukaryotic transcription factors 
that posses two functional independent domains that can be physically separated. In this 
thesis, the DNA binding domain was fused to the AChE (BD-AChE fusion protein), and the 
trans-activating domain was fused to the proteins encoded by the cDNA library (AD-
translated cDNA fusion proteins). The co-expression of these proteins was carried out in 
yeast containing reporter genes (such as Escherichia coli LacZ and the yeast gene His) that 
require the activity of the transcriptional activator for expression.  
The bait protein AChE was cloned in the pVJL11 vector (gift of J. Camonis) and fused with 
the LexA binding domain. The mouse cDNA library was cloned in the vector pACT2 
(Clontech, Heidelberg) and fused with the Gal4-AD. Both plasmids were transformed into 
L40 yeast strain, where they were expressed and transported to nucleus. In the case that 
AChE interacted with one of the library proteins, LexA-DNA-BD comes close to GAL4-AD 
and the reconstitute the transcription activator. The transcription factor was than able to 
activate the transcription of reporter genes (lacZ and HIS3). 
 
2.2.2.1. Construction of the hybrid "Bait" 
 
The complete open reading frame of mouse AChE was cloned in frame in pVJL11 
vector as a fusion construct between C-terminus of LexA binding domain and N-terminus of 
AChE. An AChE-LexA hybrid protein would be expressed by transforming the yeast cells 
with this construct. The hybrid protein was not activating the GAL4 gene, this being one of 
the basic conditions that has to be fulfilled  
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2.2.2.2. Mouse fusion cDNA library 
 
A Clontech Matchmaker mouse brain library was used. The cDNAs were cloned 
using the XhoI / EcoRI restriction sites in the pACT2 vector. The size of the cDNAs varied 
between 0.4 -4.0 kb and the average cDNA size was 2.0 kb. The number of independent 
clones 3.5X106 and the estimated % of colonies with inserts was 95%. However, the library 
data were tested and the estimated % of colonies with inserts was about 60%. The titer of 
the library was 0,335 X 109 cfu/ml (colony forming units). 
 
2.2.2.3. Small scale yeast transformation 
 
The first step in setting up a two-hybrid system was to transform the bait plasmid into 
the yeast strain L40 and to select the yeast transformants on a minimal medium lacking 
tryptophan. It was absolutely necessary to rule out the possibility of the ‘bait’ plasmid to 
trans-activate the reporter gene by itself. In order to test this, a small-scale yeast 
transformation protocol was used. Competent yeast cells were prepared using the lithium 
acetate (LiAc) method.  
10 ml YPD or DO medium were inoculated with a large L40 colony and shaken o/n at 
30°C. The next day, the 10 ml cell culture was diluted in 100 ml YPD and grown for 
additional 3 to 5 hours at 30°C. The cells were then pelleted at 3500 rpm for 5 min at RT, 
resuspended in 50 ml 0.1 M LiAc in TE pH 7.5, pelleted again and resuspended in 2 ml of 
0.1 M LiAc in TE. After one hour shaking at 30°C the yeast cells were ready for 
transformations (competent). They could also be kept overnight at 4°C for transformation 
next day. 
200 ng DNA were mixed with 100 µl competent yeast cell suspension and 500 µl 
50% PEG, 100 mM LiAc, 1XTE, vortexed and incubated at 30°C for 30 minutes. The cells 
were heat shocked for 15 to 30 minutes at 42°C, pelleted at full speed for 5 seconds, 
washed in 1 ml YPD and re-centrifuged and resuspended in 1 ml YPD. 100 µl cells were 
plated on DO/-Trp medium and incubated at 30°C for 2-3 days.  
 
2.2.2.4. Large scale yeast transformation (library transformation, Michael White)  
 
To perform a two-hybrid screen, two-hybrid plasmids must be introduced by 
transformation into the yeast reporter strain, either simultaneously or sequentially. The 
simultaneous co-transformation is preferable to sequential transformation if the expression 
of ‘bait’ protein is toxic to the cell. Otherwise the sequential transformation is recommended 
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because it gives higher transformation efficiency. For the sequential transformation, the 
library plasmids are introduced into competent yeast cells that have been previously 
transformed with the AChE bait hybrid plasmid. The most efficient screen for yeast 
transformants containing interacting proteins is to select transformants for the activation of 
the his3 reporter gene. The yeast L40 strain containing the AChE ‘bait’ is transformed with 
the pACT2 cDNA library plasmids. A typical two-hybrid screen requires 5X106 
transformants.  
One or two colonies containing the bait plasmid were grown in 25 ml DO/-Trp o/n at 
30°C on a shaker. The next day the cells were counted and diluted in 250 ml selective 
medium DO/-Trp at 5x106 cells/ml. After growing the cells for further 3 hours at 30°C to a 
concentration of 1x107 cells/ml, the suspension was centrifuged for 5 min at 3000-5000 rpm, 
RT, and the pellet was washed in 100 ml sterile water, and re-centrifuged. Another wash 
step followed, and the pellet was this time re-suspended into 50 ml of 0.1 M LiAc in TE, 
followed by centrifugation for 5 min at 3000 rpm, and the pellet was resuspended in 10 ml 
0.1 M LiAc/TE and finally, incubated on a shaker at 30°C for one hour. The now competent 
L40 yeast cells were pelleted, and resuspended in 2 ml 0.1 M LiAc/TE. To the cell 
suspension 60 µg library plasmid DNA and 20 ml 40% PEG 3350 in (LiAc 0.1 M/Tris-HCl pH 
7.5 10 mM/ EDTA 1mM) were added. The mixture was well vortexed and incubated at 30°C 
to allow the plasmids to attach the yeast cell. The L40 cells were heat shocked for 30 min at 
42°C to allow the library plasmids to enter the yeast cells. 2 wash steps followed: both in 10 
ml YPAD preceded by centrifugation at 3000 rpm, 5 min, RT. In order to increase the 
transformation efficiency and to allow cell regeneration (His selection shouldn’t be applied 
too short after transformation), the yeast cells were resuspended into 250 ml DO/-Trp/-Leu, 
and grown for about 8 hours at 30°C. The transformants were pelleted and resuspended in 
2 ml DO/-Trp/-Leu and aliquots were plated onto 10XØ140mm DO/-Trp/-Leu/-His plates. 
With this protocol the first positive clones were visible between days 3 and 5. The cells that 
could grow on these plates were selected for the presence of both pLexA-AChE and 
pGAL4cDNA library plasmid and the activation of the his3 reporter gene.  
In order to eliminate false-positive clones the activation of the second reporter gene, 
LacZ, was tested by analyzing the β-galactosidase activity (with the filter lift-assay). 
 
2.2.2.5. β-Galactosidase-Filter lift -Assay (Breeden and Nasmyth, 1985, modified 
by Neiman) 
 
The β-Galactosidase-Filter-Test is a sensitive assay to determine whether yeast 
colonies on a plate express β-galactosidase activity. The assay could be performed any 
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time after colonies became visible. The yeast cells prepared as patches were replicated with 
a replicating cylinder and a velvet on a Whatman paper laid on a plate containing the same 
medium as the one used to grow the cells. After incubating o/n at 30°C, the filter with the 
grown yeast cells was sunk into a liquid nitrogen container for 15 s. The stiff filter was laid 
on another filter soaked with the X-Gal/Z buffer (see below). After 2 to 18 hours incubating 
the filter at 30°C in dark, colonies expressing LacZ gave a more or less deep blue color. 
Strong positive colonies turn blue as soon as 30 minutes, weaker positives may take 
overnight or longer to turn blue.  
Z buffer: 
• 60 mM Na2HPO4 
• 40 mM NaH2PO4 
• 10 mM KCl 
• 1mM MgSO4, pH 7. 
Z Buffer/X-Gal solution: 100 ml buffer Z, 0.29 ml 2-mercaptoethanol and 1 ml X-Gal (2% in 
dimethyl-formamide). 
 
2.2.2.6. Selection of transformants 
 
The colonies His+/LacZ+ identified by above procedures contained both the AChE 
and the library hybrid plasmids. To further analyze these cDNA clones, it was necessary to 
separate the library plasmid from the bait AChE. E. coli strain HB101 had a defect in the 
leuB gene, which could be complemented by the LEU2 gene from yeast. The cDNA library 
vector pACT2 had the leu, but not the pLexA-AChE. Thus, pACT2 library plasmids could be 
separated from the bait AChE plasmid by transforming HB101 with the plasmid DNA 
isolated from the His+/LacZ+ clones. The bacterial transformants growing on minimal M9 
medium lacking leucine would harbor only the pACT2 hybrid plasmids. Since the plasmid 
DNA isolated from yeast contains a lot of genomic DNA, electroporation is recommended to 
introduce plasmid DNA into bacteria (see 2.2.1.1.4.). 
 
2.2.2.7. Isolation of plasmid DNA from yeast (Hoffman and Winston, 1987) 
 
His+/LacZ+ colonies were cultivated in 2 ml DO/-Leu o/n at 30°C on an incubation 
shaker. The yeast cell suspension was than centrifuged for 5 s to pellet the cells. The pellet 
was resuspended in 100 µl TE, 200 µl Lysis solution, 200 µl 
phenol:chloroform:isopropanol:25:24:1, and 300 mg glass beads. The mixture was vortexed 
for 2 min and centrifuged for 5 min at 14000 rpm RT. The supernatant was transferred to a 
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new centrifuge tube with 0.1 volumes potassium acetate (5M) and 2 volumes of ethanol 
100%. The precipitated plasmid DNA was than recovered by centrifugation 5 min at 14000 
rpm RT, washed with 70% ethanol and air or vacuum dried. The pellets were resuspended 
in 20 µl TE and 1-2 µl was used to electroporate bacteria. 
Yeast lysis solution: 
2% Triton X-100 
1% SDS 
0.1M NaCl 
0.01M Tris (pH 8) 
1 mM EDTA. 
 
2.2.2.8. Preparation of yeast protein extracts 
 
10 ml L40 culture at 2X107 cells/ml (OD 0.7-0.9) were centrifuged 10 min at 3000 
rpm, re-suspended in 1 ml H2O and transferred into a microfuge tube. The suspension was 
centrifuged again and the pellet was frozen in liquid nitrogen and re-suspended in 400 µl 
sample buffer. After some minutes of incubation on ice, 400 µl glass beads were added and 
vortexed 4 times 30 s on a maximum speed. Between each vortex step the probes were 
boiled for one min. After 15 min centrifugation on max speed the supernatant (about 100 µl) 
was transferred into a new centrifuge tube and kept at -20°C. 
Sample Buffer: 
2% SDS 
100 mM DTT 
60 mM Tris pH 6.8 
0,001% Bromphenol blue 
10% Glycerol 
Glass beads (Sigma) 0.45 – 0.50 mm diameter, soaked in 1 N HCl o/n, and washed in H2O. 
 
2.2.2.9. DNA database search 
 
DNA databases were searched in order to identify the protein sequences of the 
different AChE binding partners or to compare already known sequences. The searches 
were performed using the internet site of the National Centre for Biotechnology Information, 
USA (URL: http://www.ncbi.nlm.nih.gov). Two types of searches were carried out: GenBank 
search and Basic Local Alignment Search Tool (BLAST) search. In the GenBank database 
(National Institutes of Health, Bethesda, Maryland, USA), DNA sequences are annotated 
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and if a potential protein sequence shows similarity with an already known protein, this is 
indicated in the name of the submitted sequence. Therefore, for the current study, a search 
for AChE was performed. BLAST search of a database (Altschul et al., 1990) is carried out 
using a DNA or protein sequence as a query, and results in the identification of sequences 
with significant homology to that of the query sequence or of a part of it. A DNA database 
can be searched also with a protein sequence (translated nucleotide database search), thus 
enabling identification of similar protein sequences (e.g. of different protein isoforms) that 
are derived from not significantly similar DNA sequences. The sequences obtained from the 
searches were analyzed on a PC, using Genedoc software. 
 
2.2.3. Protein analysis 
 
2.2.3.1. The Bradford Assay (Bradford, 1976) 
 
The Bradford protein assay is one of several simple methods commonly used to 
determine the total protein concentration of a sample. The method is based on the 
proportional binding of the Coomassie dye to proteins. Within the linear range of the assay 
(~5-25 µg/ml), the dye-protein binding is also linear. Furthermore, the assay is colorimetric; 
as the protein concentration increases, the color of the test sample becomes darker. The 
protein bound Coomassie Brilliant Blue G-250 absorbs at 595 nm (Unbound dye has also 
another absorbance wavelength, R-250 likewise). The protein concentration of a test 
sample is determined by comparison to that of a series of protein standards known to 
reproducibly exhibit a linear absorbance profile in the assay. Although different protein 
standards can be used, the most widely used protein standard, Bovine Serum Albumin 
(BSA), was chosen. 
Procedure 
A BSA standard reference curve was generated from a standard 1 mg/ml BSA stock 
solution: 100, 80, 60, 40, 20, 10, 0 µg/ml. For the microtiter plate assay 20 µl sample and 
200 µl Bradford reagent were mixed for 10 min at RT. OD is measured at 620 nm in a 
microplate reader. For the standard test, 100 µl of probe were mixed with 1 ml Bradford 
reagent and the OD was measured at 595 nm. 
Bradford reagent 
0.01% Coomassie Brilliant Blue G-250 
4.7% ethanol  
8.5% H3PO4
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2.2.3.2. Ellman activity assay (1961) 
 
The use of thiocholine esters together with the Ellman reagent allows colorimetric 
detection of cholinesterases. This type of reaction in which the free sulfhydryl product of the 
enzymatic hydrolysis reacts with 5, 5'-dithio-bis(2-nitro benzoic acid) (DTNB) is presented 
below: 
 
Acetylthiocholine
 
 
 
Thiocholine + 
acetate 
 
+ 
DTNB 
 
The assay measures the increase of OD at 412nm (due to the formation of a yellow 
product) with the time, in a 3 minutes interval. The following reagents were pipetted in a 
spectrophotometer cuvette: 
2 mM acetylthiocholine iodide (substrate for AChE) 
40 mM MOPS 
0.25 mM DTNB 
10-5M Ethopropazine (inhibitor for BChE) 
50µl Probe 
to an end volume of 500µl. 
The activity was measured and calculated using the KinLab software from Perkin 
Elmer. 
 
 
2.2.3.3. SDS-polyacrylamide gel electrophoresis (SDS-PAGE, Laemmli, 1970) 
 
By SDS-polyacrylamide gel electrophoresis (SDS-PAGE), proteins are separated 
according to their molecular weight. All solutions used are Tris-based buffers, containing 
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SDS. The function of SDS is to unfold the proteins by binding to their hydrophobic groups 
and to provide them with a negative charge, irrespective of their isoelectric point. Before 
subjected to electrophoresis, proteins are mixed with a buffer, apart from SDS, which also 
contains β-mercaptoethanol, a reducing agent that breaks disulfide bonds and thus 
separates multisubunit proteins to their monomers. The effect of β-mercaptoethanol is 
assisted by heating the sample at 100°C.  
The electrophoresis gel consists of two parts: a) the stacking gel, a low concentration 
gel of pH 6.8 which functions to focus the different proteins of the loaded samples and b) 
the separation gel, a higher concentration gel of pH 8.8 in which proteins are separated. 
The separation gel was first prepared (see below). The concentration of the gel varied, 
according to the area of protein size where separation was required to be optimal, low 
molecular weight proteins separate better in high concentration gels and high molecular 
weight proteins in low concentration gels. The mixture was loaded into the running cassette 
and overlaid with H2O. The stacking gel was prepared (see below), loaded on top of the 
separation gel and a well separator was inserted. After polymerization, the running cassette 
was placed into a chamber, which was filled with running buffer (see below). The well 
separator was removed and wells were washed with running buffer. Protein samples were 
mixed with an equal volume of 1x sample buffer (see below), heated at 100°C for 3-5 min 
and loaded into the wells of the gel. A molecular weight standard was also loaded, which 
enabled the estimation of the molecular weight of the proteins analyzed. Pre-stained 
standard was used for western blot or Coomassie-blue staining application, respectively. 
Electrophoresis was carried out at 150 V for 1 h.  
Gels were used either for Western blot or for Coomassie-blue staining. The 
composition of the gel mixtures, as well as of the other solutions used is shown below: 
 Separation gel (7.5%) Stacking gel (4%) 
dH2O 4.8 ml 3 ml 
Tris buffer 2.5 ml (1.5 M, pH 8.8) 1.25 ml (0.5 M, pH 6.8) 
30% Acrylamide 0.8% bis 
acrylamide 
2.5 ml 0.65 ml 
APS 10% 100µl 100µl 
SDS 10% 50µl 50µl 
TEMED 5µl 5µl 
 
Running buffer: 
0.25 M Tris, 1.9 M glycine, 1% SDS, pH 8.8 
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6x Sample buffer: 
0.125 M Tris, 4.6% SDS, 20% Glycerol, 5% β-mercaptoethanol, small amount of 
bromophenol blue, pH 6.8 
 
2.2.3.4. Western blot (Towbin et al., 1979) 
 
Western blot analysis enables high sensitivity detection of a specific protein in a 
protein mixture, when an antibody against an epitope of a particular protein is available. The 
various proteins of the mixture are separated in an SDS-PAGE gel and transferred to a 
nitrocellulose membrane. The membrane is then subjected to immunodetection.  
 
2.2.3.4.1. Transfer of proteins to a nitrocellulose membrane 
 
After SDS-PAGE, the stacking gel was removed and the separation gel was 
assembled together with the membrane wetted with transfer buffer. Four sheets of blotting 
paper were placed on both sides of the assembly. Proteins were transferred 
electrophoretically at 300 mA for 1-2 h. The membrane was stained with Ponceau-S (see 
below) for 1-2 min, a reversible stain, to verify protein transfer. Protein bands were 
visualized after destaining with H2O. The membrane was further destained with T-PBS 
(phosphate buffer saline (PBS) with 0.05% Tween 20) for 1-2 min. Solutions used:  
Transfer buffer: 0.025 M Tris, 0.19 M glycine, 20% methanol. 
Ponceau-S stain: 5% acetic acid, 0.2% Ponceau-S. 
 
2.2.3.4.2. Immunodetection 
 
For the immunodetection of the protein of interest transferred on a nitrocellulose 
membrane, the membrane was first incubated with a blocking buffer containing a rich 
source of natural proteins. The reason for this blocking was to allow weak, unspecific 
binding of the protein source of the buffer to all the proteins transferred onto the membrane. 
The membrane was then incubated with an antibody against an epitope of the protein of 
interest (primary antibody) in blocking buffer for 1h at room temperature or o/n at 4°C. The 
antibody binds to the protein of interest in a competitive fashion with the proteins of the 
blocking buffer. This results in high specificity of binding and elimination of background. 
After washing 3x5 min with T-PBS the membrane was incubated with a secondary antibody, 
also in blocking buffer, which binds to the primary antibody. The secondary antibody is 
conjugated with horseradish peroxidase (HRP). Incubation with the secondary antibody 
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(1:10000, unless otherwise stated) was done in blocking buffer at RT for 60 min. After 
washing 3x15 min with T-PBS the membrane was developed using a chemiluminescence 
detection kit (Amersham). 
Blocking buffer: 5% milk powder in T-PBS 
T-PBS: PBS with 0.5% Tween 20 
 
2.2.3.5. Coomassie-blue staining of SDS-PAGE gels 
 
Coomassie-blue (Coomassie Brilliant blue R 250) is an irreversible, unspecific 
protein stain, suitable for staining of SDS-PAGE gels for the detection of differences 
between a particular protein sample and a control sample, when relatively high amounts of 
protein are present (microgram). Gels were incubated with the following staining solution for 
15 min, destained with 10% acetic acid for 2 h and washed with H2O. 
Staining solution: 
25% isopropanol 
10% acetic acid 
0.05% Coomassie-blue R-250. 
 
2.2.3.6. Silver staining of polyacrylamide gels  
 
The silver staining of the gels was made according to the producer’s protocol. Silver 
stain Plus, Bio-Rad. 
 
2.2.4. Cell culture 
 
All experiments and treatments of cells were performed under sterile conditions using 
the sterile hood. Solutions and media were sterilized either by autoclaving or filtering, and, 
were pre-warmed before use (in a 37°C water bath). All glassware items, such as pipettes 
and bottles were autoclaved before use, and rinsed with 70% ethanol before taken under 
the sterile hood. 
 
2.2.4.1. Basic handling of the cells, cell passage 
 
Cells were trypsinized and resuspended in complete DMEM medium, and, split one 
to eight just before confluence was reached. Normal culture medium was 10% FCS/ 2 mM 
glutamine/20U Pen/20 µg Strep (penicillin and streptomycin) from Bio*Whittaker in 500 ml 
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DMEM. Trypsinization required the prior washing of the cells in PBS. The cells were then 
incubated 1 min with 500 µl Trypsin-EDTA in a 9 cm diameter plate and gently scraped to 
detach them. To inactivate the trypsin, 5 ml medium were added and a 700 – 800 µl of 
suspension was transferred to new culture dishes. The cells were grown in an incubator at 
37°C with 5% CO2, 97% humid atmosphere.  
For stocks: Cells were washed with PBS; treated with trypsin (500 µl pro culture 
dish); scraped; centrifuged at 700 rpm for 5 minutes, and then the supernatant was 
removed. The pellet was resuspended in 80% DMEM /10% DMSO /20% FCS and the cells 
were transferred immediately on ice in cryotubes, and placed into the liquid nitrogen tank in 
which they can be kept for years. 
 
2.2.4.2. Transfection 
 
HEK293 cells were transfected using the DOTAP method. DOTAP is a liposome 
formulation of a monocationic lipid (N-[1-(2,3-Dioleoyloxy)]-N,N,N-trimethylammonium 
propane methylsulfate). Mixing DOTAP Liposomal Transfection Reagent with DNA results in 
spontaneously formed stable complexes. These complexes were added to the tissue culture 
medium (with or without serum) and the resulting mixture was added to the cells. These 
complexes adhere to the cell surface, fuse with the cell membrane, and then release the 
DNA into the cytoplasm. This method of DNA transfer is very gentle, without cytotoxic 
effects, so that the cells could be transfected with high efficiency.  
 
Structure of DOTAP (C43H83NO8S, MW: 774.21)  
 
One hour before transfection, the cells were transferred to 2% FCS DMEM. 5 µg of 
plasmid DNA were used for each 9 cm diameter culture dish. The DNA was diluted in 
DMEM. At the same time, 32 µl DOTAP were diluted in DMEM to a final volume of 100 µl, 
and both solutions were mixed without vortexing. After 10-15 minutes of incubation at room 
temperature, the DNA/DOTAP mixture was added to the cells (1x106 cells/9 cm plate) in 
serum-free medium. 6 to 8 hours later, the medium was replaced with 10% FCS-containing 
medium. After 48 h the cells were collected and lysed. 
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2.2.4.3. Cell lysate preparation 
 
For western blot and immunprecipitation analysis of the expressed protein, cells were 
lysed and the soluble fraction was collected. Cells were harvested 48 h after transfection. 
Plates were washed twice with 2-3 ml of ice cold 1 x PBS buffer. 1 ml of lysis buffer was 
then applied to each 9 cm plate. Cells were scraped with rubber scraper, incubated for 10 
minutes on ice and the cell suspension was transferred to Eppendorf tubes standing on ice. 
The suspension was centrifuged at 12000 g, at 4°C for 10 min and the supernatant was 
recovered and kept at -20°C. 
Lysis buffer 
50 mM Tris, pH 8.0 
0.1% TritonX-100 
80 mM NaCl 
Protease inhibitor cocktail (Sigma). 
 
2.2.4.4. Mouse brain membrane extract 
 
Membrane protein extracts prepared from brains of mice were used for the co-
immunprecipitation experiments. Mice were sacrificed by cervical dislocation and the brain 
was collected and stored frozen at -80°C or directly homogenized in 10 ml of 
homogenization buffer plus fresh protease inhibitors (see below) with a sonicator by 4 times 
20 s pulses. Cellular debris was removed by ultracentrifugation at 150000 g at 4°C for 60 
min. The pellet, which contained membranes, was resuspended in 10 volumes extraction 
buffer (see below) plus protease inhibitors with a sonicator 4 times 20 s pulses. The extract 
was centrifuged at 150000g, at 4°C for 60 min. The supernatant, the final mouse brain 
membrane extract, was saved, aliquoted and stored at -80°C. Protein content (Bradford) 
and cholinesterase activity (Ellman) was determined in different fractions. The buffer was 
then changed by dialysis with PBS-T, to minimialize the high salt content interference with 
the binding studies. 
Homogenization buffer 
10 mM Tris-HCl, pH 7.4 
1 mM EDTA 
0.02% NaN3
Protease inhibitors (Sigma) 
Extraction buffer 
20 mM Sodium-phosphate, pH 7.0 
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1 mM EDTA 
1 M NaCl 
0.5% Triton X-100 
0.02% NaN3 
Protease inhibitors. 
 
2.2.4.5. Co-immunoprecipitation  
 
Co-immunoprecipitation is a biochemical technique commonly used to demonstrate 
in vivo protein-protein interactions. If two proteins are interacting in vivo, then the direct 
immunoprecipitation of one protein with an antibody specific to that protein should 
precipitate other associated proteins.  
Transfected HEK293 cells were lysed in PBS with 0.1% Triton X-100 plus complete 
protease inhibitors. The cell lysate (1 ml) was then incubated with anti-AChE or anti-Laminin 
antibodies (5 µg) at 4°C o/n, followed by incubation with Protein A/Sepharose for 1 h at 4°C. 
Likewise, the brain membranes fraction (1 ml) was subjected to immunoprecipitation by anti-
AChE or anti-Laminin antibodies. Beads were washed six times by PBS plus 0.1% Triton X-
100, and the proteins were eluted by 1x SDS sample buffer (30 µl). The associated proteins 
could be visualized by Western blot analysis. 
 
2.2.5. Stainings 
 
2.2.5.1. Preparation of mouse brains and chicken retinas for cryostat sectioning 
 
For morphological applications on mouse brains, the brain and retina were fixed and 
cryoprotected. Preparation methods varied, according to the age of the mouse and the 
desired fixation. Mice at age day 3 (P3) or older were anaesthetized with chloroform and 
perfused. Through perfusion, the blood of the animal was removed and the whole mouse 
body was fixed. PBS was used to remove the blood. For the majority of the applications, 4% 
paraformaldehyde in 0.1 M PBS was used for fixation. After perfusion, the brain was 
collected, kept in fixative at RT for 2 h and then in 25% sucrose at RT o/n. The sucrose 
incubation (cryoprotection) protects the brain from the low temperatures used in cryostat 
sectioning, by increasing its osmolarity. When not used immediately after cryoprotection, the 
brains were kept in 25% sucrose at 4°C. 
Chicken embryos at different embryonic stages were isolated from eggs, decapitated 
and the eyes were enucleated. Following 3 wash steps in PBS (5 min), the eyes were fixed 
Materials and Methods 
 
45
in 4% formaldehyde o/n at 4°C (E9-E19) or 1 h at RT (E4-E8). The fixative was removed 
and the eyes were transferred into 25% sucrose. The eyes were let in the sugar solution 
until they completely sunk.  
 
2.2.5.2. Cryostat sectioning 
Brains and eyes were covered with embedding Tissue Tek and frozen at -20°C - -
30°C. After freezing, they were equilibrated at -22°C. Sectioning was carried out with 
chamber temperature -25°C and object temperature -22°C. Sagittal or coronal sections 
were cut. For most immunohistochemical applications, 20 µm sections were cut. Retinal 
sections were 10 µm thick. Sections were mounted directly on glass slides with 0.5% gelatin 
and assayed on them.  
 
2.2.5.3. Immunohistochemistry 
Immunohistochemical staining was carried out on mouse brain sections in order to 
co-localize AChE with its binding partners. The general protocol is given below. However, 
this protocol was quite often modified in one or more of its parameters, or slightly different 
protocols were applied in parallel, in an attempt to optimize staining.  
General control methods 
All antibodies and antisera were characterized by the companies or by the groups 
from which they were obtained. The specificity of immunolabelling was further verified by 
the omission of the primary antibody from the protocol. This resulted in a lack of 
immunocytochemical fluorescent signal upon microscopic examination. Varying dilutions of 
secondary antibody enabled the optimal concentration of fluorescence to be established in 
order to avoid background labeling.  
General protocol 
The sections were dried on a heating block and incubated in 0.5% Triton X-100 in 
PBS at RT for 15 min, shortly washed with PBS and blocked with 3%BSA in PBS at RT for 
1 h. The primary antibody was diluted in 0.1% Triton X-100 PBS, and incubated at 4°C o/n 
(see results section for concentrations used). After 3 washing steps with PBS-T the sections 
were incubated with the secondary antibody 1:100, in PBS-T at RT for 30 min. The excess 
of unbound second antibody was washed 3 times with PBS-T and the sections were 
incubated for 1 min with DAPI (stains the nucleus). After 2 washing steps with PBS, the 
sections were dried on a heat block, and mounted in glycerine.  
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2.2.5.4. Karnovsky and Roots cholinesterase activity staining (1964) 
 
The enzymatic activity is assayed by the formation of an insoluble brown precipitate 
(Hatchett’s brown) that is visible on a light microscope. The retinal or brain cryostat sections 
were dried on a heat block at 37°C and incubated 2 times for 15 min in a 0.1 M Tris-Maleate 
buffer. After this step of equilibration, the sections were incubated for up to 4 hours in dark 
at 37°C in the following solutions mix: 
0.1% ATC (substrate for AChE) 
0.065 M Tris-Maleate buffer, pH6 
0.1 M C6H5Na3O7X2H2O 
30 mM CuSO4
iso-OMPA 10-3 M 
5 mM K3Fe(CN)6
As control for the staining the above solution was used, but without ATC. 
After the incubation time, the sections were washed 2 times 10 min in distilled water and 
dried on a heat block. 
Buffers: 
0.1 M Tris-Maleate Buffer pH 6 
12.2 g Tris 
11.6 g Maleic acid. 
 
2.2.5.5. In situ hybridisation on cryostat sections 
 
Digoxigenin probe synthesis was made using the DIG RNA-labeling kit from Roche. 
The in situ hybridization procedure can be split in 5 main steps: 
1. Hybridization 
The sections were defrosted at room temperature (about 1 hour) and in this interval 
the riboprobes were diluted in hybridization buffer (0.1-1µg/ml) and denatured for 10 min at 
70°C. 150µl probe were added to each section and the slides were covered with a 22 x 50 
mm sterile coverslip. The probes were hybridized o/n at 65°C in a sealed box with 2XSSC 
and 50% formamide. 
Hybridization buffer: 1 ml 10X Salts, 5 ml formamide, 2 ml 50% dextrane-sulfate, 1 ml 
yeast-RNA, 100 µl 50X Denhardts, 900 µl H2O. 
50% Denhardts: 1% BSA, 1% Ficoll, 1% polyvinylpyrollidon. 
2. Posthybridization 
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The slides were transferred to a slide rack and incubated at 65°C in washing solution 
(see below) for 10 minutes. The coverslips should normally fall off the slides at this step. 
After the first wash interval, two more wash steps followed, both of them for 30 minutes in 
washing solution at 65°C. The sections were than equilibrated in another buffer, MABT, 2 
times for 30 min at RT. 
Washing Solution: 1x SSC, 50% formamide, 0.1% Tween-20, pre-warmed to 65°C.  
MABT: 100 mM Maleic acid, 150 mM NaCl, pH 7.5, 0.1% Tween-20. 
3. Blocking and antibody staining 
The solution on the slide was removed and the sections were blocked in 20% heat 
inactivated goat serum in MABT for at least one hour at RT, without a coverslip. After the 
blocking, the sections were stained with 100µl anti-DIG alkaline phosphatase 1/2000 to 
1/5000 diluted in MABT + 20% heat-inactivated goat serum, for o/n at RT in a humid 
chamber. 
4. Post antibody washes 
The sections were washed at RT in MABT for 1 hour each 2-3 times and after with 
the AP-buffer for 2 times 10 minutes at RT. After washing the unbound antibody, the 
alkaline phosphatase substrate was given (100µl of 1% NBT/BCIP in AP-Buffer) and 
incubated for a few hours or o/n in dark at RT. 
AP-Buffer: 0.1M Tris, pH 9.5, 0.05M MgCl2, 0.1M NaCl, 0.1% Tween-20. 
5. Staining reaction 
The staining reaction was stopped by washing with PBS 2 times 30 minutes at RT. 
The sections were embedded in Kaisers Glycerin-gelatine (60 µl) and coverslips were 
added on the slides. 
 
2.2.5.6. Microscopy 
 
The staining was viewed and documented on an Axiophot (Zeiss) microscope, 
equipped with fluorescence and a camera. The pictures were taken using the Kamcon 
software and processed using the Adobe Photoshop 7.0 software. 
 
2.2.6. Surface plasmon resonance 
 
This method was used primarily to identify and characterize non-covalent interaction 
between surface-immobilized AChE and a brain membrane extract. The BIAcore 3000 
instrument was used. This instrument use an optical method to measure the refractive index 
near (within ~ 300 nm) a sensor surface (see Figure 5).  
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Figure 5. Illustration of the combined surface plasmon resonance – mass 
spectrometry approach. First, a derivatized biosensor chip, having four flow cells, was 
used in the analysis of interaction between surface-bound AChE and solution-ligand(s). The 
chips was removed from the BIAcore 3000 and inserted into the mass spectrometer. 
 
In the BIAcore instrument the sensor surface was forming the floor of a small flow 
cell, 20-70 nl in volume, through which an aqueous solution passes under continuous flow 
(with a speed of 1-100 µl/min). In order to detect an interaction AChE was immobilized onto 
the sensor surface. The process of immobilization of AChE to the chip surface is called 
derivatization. Its binding partner(s) (unknown, possibly present in a brain extract) was 
injected in aqueous solution through the flow cell, under continuous flow. As the proteins 
bound to AChE, the accumulation of protein on the surface resulted in an increase in the 
refractive index. This change in refractive index is measured in real time, and the result 
plotted as response or resonance units (RU) versus time (sensogram). A response is also 
generated as a difference in the refractive indices of the running and sample buffer. This 
background response was subtracted from the sensogram. One response unit (RU) 
represents the binding of approximately 1pg protein/mm2.  
A CM5 (carboxylated dextran) chip was used. All four flow cells of the sensor chip 
were activated through exposure to N-hydroxysuccinimide [0.1 M prepared in 20 mM 
HEPES, 0.005% surfactant P20, 150 mM NaCl, 3 mM EDTA, pH 7.4, containing 0.1 M N´-
ethyl-N´-(dimethylaminopropyl)carbodiimide], derivatized with AChE or neuroligin-1. The 
remained free carboxyl groups on the chip after derivatization were blocked by exposure to 
1 M ethanolamine hydrochloride. 
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3. Results 
 
PART I: Is neurexin-1β a possible AChE binding partner? 
     Co-localization and binding studies. 
 
Neurexins are relatively “new” molecules (Südhof et al., 1995). At the beginning of 
this work in 2001 not too many histological localization studies about neurexins were 
published. Therefore, before starting the binding experiments, the retinal expression pattern 
of neurexin-1β was analyzed by in situ hybridization and compared with the AChE 
expression pattern. The in situ hybridization method was not established in the lab until that 
time point. Therefore, the distribution of a series of other markers, e.g. synaptotagmin, 
neurofilament M, and tyrosine hydroxylase, was studied. These markers were used as 
controls to establish the accuracy and reliability of the method.  
 
3.1.1. AChE and neurexin-1β localization in the developing retina 
 
The first step on the way to show the direct connection between AChE and neurexin-
1β was to show that they co-localize in the same CNS regions. Due to its highly organized 
layered structure of alternating neuronal cell bodies and neurites, the retina presents some 
advantages over other parts of the CNS for the study of developmental processes, 
especially synaptogenesis. 
The expression pattern of neurexin-1β mRNA was analyzed by in situ hybridization. 
A 256 bp long neurexin-1 chicken riboprobe was used (Patzke and Ernsberger, 2000). 
Embryonic chick retina sections, 10-15 µm thick, corresponding to the E4 (E-embryonic day) 
up to E19 were hybridized with the above mentioned fragment. As control for the specificity 
of binding, a fragment synthesized in the ‘sense’-orientation was used. No signal was 
present on the sections incubated with this fragment. Figure 7 shows retinas at different 
developmental stages hybridized with the neurexin probe. The neurexin-1β staining 
revealed an early appearance of this transcript in the retina. The first signal for neurexin was 
detected at E6 (Figure 7E) in the ganglion cell layer. At E9, the neurexin-1β transcripts 
appeared not only in the GCL, but also in the inner half of the INL (Figure 7H). The staining 
remained localized on the GCL and the inner half of INL (where most of the amacrine cells 
are localized) until the E19 stage (Figure 7K). E19 displayed the same expression pattern, 
except that here some cells situated at the border to the OPL (possibly horizontal cells) 
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were also labeled (Figure 7H). The absence of a commercially available antibody against 
chicken neurexin limited the expression studies to the mRNA level.  
In parallel, retinas from E4 to E19 were stained with an anti-AChE antibody (clone 
3D10, Tsim et al., 1988). The omission of the primary antibody from incubations resulted in 
the absence of immunolabeling within the retina. Figure 7A, C, F, I, and L, shows 3D10 
labeled neurons which are starting to differentiate and later perform synaptogenesis. The 
first cells to be stained are ganglion cells, followed by amacrine cells situated in the INL. 
The strong AChE labeling in the IPL is associated with the formation of synaptic 
connections. Karnovsky-Roots activity staining was performed on the same set of retinal 
developmental stages. The staining was not only consistent with histochemical protocols for 
AChE, but also with the previously described immunostaining, being found in ganglion, 
amacrine and horizontal cells and in 2 bands in the IPL (Millar et al., 1987). The Karnovsky-
Roots technique is a procedure based on the AChE activity. This assay stains just the active 
protein in a tissue and thus provides more information related to the presence of an active 
or inactive enzyme. The same cell populations labeled with 3D10 were also histochemically 
stained with the Karnovsky-Roots method, showing that during retinal development AChE is 
expressed in an enzymatically active form.  
By comparing the neurexin-1β expression pattern with AChE, it could be concluded 
that the neurexin-1β labeled cells are also AChE labeled, and temporally neurexin-1β 
follows with a 2 days delay the AChE expression. 
 
 
Standard abbreviations: 
RPE- retinal pigment epithelium, 
ONL- outer nuclear layer 
OPL- outer plexiform layer 
INL- inner nuclear layer 
IPL- inner plexiform layer 
GCL- ganglion cell layer 
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Figure 7. Localization of AChE and neurexin-1β in the developing chicken retina. (A), 
(C), (F), (I), (L) are retinas stained with a mouse anti-AChE chicken antibody (red) and DAPI (blue). 
(B), (D), (G), (J), (M) show a Karnovsky-Roots AChE activity staining at stages E4, E6, E9, E13, and 
E19, respectively. (E), (H), (K), (N) are retinas probed with a neurexin-1β fragment by in situ 
hybridization. Scale bar 100 µm. 
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3.1.2. Chicken retinas display synaptotagmin I distribution similar to neurexin-1β 
 
To have a further control of the neurexin-1β expression pattern, the distribution of 
synaptotagmin I in the retina was investigated by in situ hybridization. Synaptotagmin I is a 
synaptic vesicle protein that binds Ca++ ions, and forms complexes with the cytoplasmic 
domains of neurexins (Petrenko et al., 1991). Therefore, the neurexin expression pattern 
should overlap synaptotagmin’s expression pattern and relate to the same cell populations. 
Figure 8 shows an assembly of different retinal developmental stages used to hybridize with 
a DIG-labeled synaptotagmin RNA probe (Campagna et al., 1997). By comparing Figure 8A 
with Figure 7E it can be seen that starting with the same embryonic day, synaptotagmin I is 
indeed expressed in the same cells as neurexin-1β. The synaptotagmin transcript “follows” 
the neurexin-1β transcript throughout retinal development (see Figure 7H, K, N, and Figure 
8C, E, G, respectively). The first signal appeared at E6 and was localized in the ganglion 
cell layer (see Figure 8A). At E11, when the IPL is already formed, the synaptotagmin 
positive cells split into 2 populations: the ganglion cells and cells situated in the inner half of 
the INL. These 2 populations continued to be labeled until E19. Figure 8E and 8G show that 
besides the above described cell populations there is also a synaptotagmin I signal in the 
outer segments of photoreceptors. This was surprising, yet cannot be explained as a 
staining artifact, since hybridizing with a ‘sense’ probe would give no signal.  
The results showed that the synaptotagmin I expression pattern overlaps with 
neurexin-1β expression in the chicken developing retina.  
 
3.1.3. Neurofilament M – a possible ganglion cell marker in the chick retina? 
 
The differentiation of a retinal progenitor into a mature cell requires the expression of 
a large number of molecules. These molecules can serve as markers for the study of 
developmental steps. Therefore, expression studies for neurofilament M were performed in 
the chick retina. Sections of different retinal stages were probed with a 553bp chicken 
neurofilament probe (Stanke et al., 1999). Figure 9 shows that starting with E6 up to E19 
the neurofilament M gene expression could be found exclusively in the ganglion cell layer. 
This localization, distributed in a constant manner in the developing retinas suggested that 
neurofilament M should be considered a marker for the ganglion cells. Nevertheless, 
immunostainings with an antibody against chicken neurofilament M should also be done, in 
order to localize the protein in the retina.  
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Figure 8. In situ hybridization with a chick synaptotagmin I probe. (A), (C), (E), (G) 
retinas corresponding to E6, E11, E17, and E19, respectively, stained for synaptotagmin (blue). E- 
Embryonic day. (B), (D), (F), (H) represent DAPI staining of the same developmental stages. ONL-
outer nuclear layer, OPL-outer plexiform layer, INL-inner nuclear layer, IPL-inner plexiform layer, 
GCL-ganglion cell layer. Scale bar 100 µm. 
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Figure 9. In situ hybridization with a neurofilament M probe. (A), (C), (E) and (G) show 
retinas hybridized with a neurofilament M riboprobe. The labeled cells are blue. (B), (D), (F) and (H) 
represent retinas stained with DAPI. Cell nuclei are blue. Scale bar 100 µm. 
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3.1.4. Tyrosine hydroxylase (TH) 
 
When the levels of ChAT (choline acetyltransferase) and ACh were compared with 
the activity of AChE, the AChE activity was much higher. It is known that there are 
potentially other sources of AChE except the cholinergic neurons, including GABAergic 
terminals, or even GABAergic neurons (Henderson and Greenfield, 1984). Tyrosine 
hydroxylase is a marker for both noradrenergic and dopaminergic neurons, since it is the 
key enzyme in the production of these two neurotransmitters. In situ hybridizations with a 
chicken TH riboprobe were performed mainly as a positive control for the in situ 
hybridization procedure. Chick TH cDNA was a kind gift of Dr. Uwe Ernsberger (Ernsberger 
et al., 1995). It is already documented in mice (Haverkamp and Wässle, 2001) that TH is 
expressed in a specific population of amacrine cells in the retina, situated at the INL border 
with the IPL. In the chicken retina, the same distribution as the one described in the 
literature was observed. Just about 7 - 10 cells/retina were TH positive. Figure 10 illustrates 
these cells and their morphology and position.  
 
 
Figure 10. TH-positive neurons in the chicken retina. The labeled cells are blue. Scale bar 
100 µm. 
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3.1.5. On the way for finding an AChE interaction partner – surface plasmon 
resonance experiments 
 
The co-localization of AChE and neurexin-1β in the retina are not sufficient evidence 
that the two proteins indeed do interact. Therefore, interaction studies were to be done. 
These studies were stopped because Prof. Taylor (UCSD) shared unpublished information 
and later published experiments that showed that AChE does not bind to neurexin-1β in the 
experimental system used (Comoletti et al., 2003). The system that they used to study the 
binding was based on the surface plasmon resonance, an in vitro method that allows 
detection of binding between pg amounts of protein. However, this does not exclude the 
possibility that AChE binds to neurexin-1β in vivo. Therefore, the use of other experimental 
approaches, e.g. co-immunoprecipitation, can bring new insights into the AChE-neurexin 
relation. As cell adhesion molecules, neurexins are known to be expressed in hundreds of 
isoforms. This leaves open the possibility that one neurexin isoform might interact with 
AChE during development. Nevertheless, the study of these possible interactions 
represents a complex project with an outcome much too unsure for a PhD work. 
The aim of the project became then the search for an unknown binding partner for 
AChE that should have a synaptic localization. A first attempt was made using 
biomolecular interaction analysis mass spectrometry (BIA/MS). This is a two-
dimensional analysis technique. In the first dimension the surface plasmon resonance 
(SPR) is used to detect the binding molecules and in the second dimension these molecules 
can be analyzed by mass spectrometry. 
 
3.1.6. Establishing a protocol for sample recovery from a BIAcore chip for mass 
spectrometry 
 
In order to identify binding partners for AChE, the first step was to immobilize AChE 
on a Biacore CM5 chip and to flow a brain extract over this chip. The proteins bound to the 
chip (and so to AChE), were recovered in a buffer and further analyzed. The Biacore 3000 
Software includes a microrecovery function designed for recovering material from the 
sensor surface in a very small volume. A protocol had to be established. For this procedure 
neurexin-1β and neuroligin-1 were used. A direct binding of these two proteins was already 
documented (Ichtchenko et al., 1995, Ichtchenko et al., 1996, Comoletti et al., 2003). 
Neuroligin was covalently immobilized on a CM5 chip (carboxymethyldextran surface) 
through its amino groups, following the standard coupling protocol with EDC/NHS - N-ethyl-
N´-(dimetylaminopropyl) carbodiimide/N-hydroxysuccinimide (Johnsson et al., 1991). With 
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this procedure the carboxylated dextran is activated, the protein is covalently bound to the 
chip through amine/NHS displacement; the remaining NHS in solution is later blocked by 
exposure to ethanolamine. Figure 11 shows that there was a response of 8500 resonance 
units (∆RU - response units) which amounts to the immobilization of 86 pmol neuroligin 
(1000 RU represents ~ 1 ng protein). This amount of neuroligin-1 bound to the chip is 
considered to be a high-density ligand surface. Neurexin-1β was diluted in 0.01M HEPES, 
0.15M NaCl, 3 mM EDTA, 0.005% P20 surfactant (HBS-EP) and injected over the 
neuroligin-1 flow cell with a constant flow rate of 1µl/min.  
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Figure 11. Neuroligin-1 immobilization on a CM5 chip. (A) Schematic representation of the 
experimental design. (B) After the activation of the carboxymethyl matrix with a 35 µl injection of 
EDC/NHS, a 200 µl aliquot of neuroligin-1 was injected over the second, third and fourth flow cell 
(green, blue and purple line), followed by 35 µl ethanolamine injection. The amount of immobilized 
neuroligin-1 corresponds to a ∆RU=8500. RU - resonance units. 
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Figure 12 shows the binding of neurexin-1β to neuroligin-1 and also the amount of 
neurexin recovered. Using the program illustrated in Figure 13 it was possible to recover the 
bound neurexin-1β in a total volume of 7 µl buffer (HEPES). This volume was re-injected on 
the CM5 neuroligin channel. This re-injection had two purposes: 
 
• to determine if there was any neurexin-1β recovered (this showing a binding to 
neuroligin-1); 
• to verify how much from the injected neurexin-1β was recovered.  
 
 
 
Figure 12. Sensogram resulting from the injection of 20µl 1µM neurexin-1β over the 
surface of a neuroligin-1-derivatized flow cell. ∆RU=140 indicated the retention of 140 pg 
neurexin-1β. The bound material was recovered by injecting 7 µl HEPES using the program 
illustrated in Figure 13. 
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Figure 13. Program developed to recover bound material from a BIAcore AChE 
derivatized chip. 
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Figure 14. Determination of the amount of neurexin-1β recovered through 
comparison with a series of standard neurexin concentrations. 
 
The 140 pg material obtained by injecting neurexin-1β over a neuroligin surface (see 
Figure 12) were recovered and reinjected over the same surface. The same ∆RU=140 was 
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concentrations, the amount of neurexin-1β recovered was estimated to 150 nM (see Figure 
14). The recovery procedure was established with a minimal loss of the material bound and 
therefore further used for AChE ligand fishing. 
 
3.1.7. Using the surface plasmon resonance to find AChE binding partners 
 
Using the protocol described in the 3.1.6., a sufficient quantity of mouse AChE (100 
fM) was immobilized to a CM5 sensor surface (sensogram not shown). A 50µl brain extract 
aliquot was injected with a very low speed 1 µl/min over the 3 flow channels derivatized with 
AChE. Figure 15 shows the sensogram resulted from this injection. 
 
 
 
Figure 15. Sensogram resulting from the injection of a 50 µl brain extract over the 
surface of an AChE derivatized flow cells. 
 
A specific binding of 1350 response units was observed which corresponds to 1.35 
ng protein. These results showed that there were proteins that specifically or nonspecifically 
bind to AChE. To gain some information about the nature of the fished AChE ligand(s), a 
recovered aliquot was analyzed by SDS-PAGE and silver staining. Figure 16 shows the 
silver staining of the proteins bound to an AChE derivatized chip and recovered using the 
established protocol (3.1.6.), separated on a SDS-gradient gel (4%-20%). 
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A                  B            C                D 
Figure 16. Silver staining of the material recovered from BIAcore chips. (A) Material 
recovered after the injection of a brain extract over a neuroligin-1 derivatized surface, subjected to 
SDS-PAGE followed by silver staining. (B) Material recovered after the injection of a brain extract 
including 1 ng purified neurexin-1β over a neuroligin-1 derivatized surface. (C) Molecular weight 
marker. (D) Material recovered after the injection of a brain extract including 1ng neurexin-1β over an 
AChE derivatized surface. 
 
Figure 16, lane A, shows that a brain extract was used for establishing if neuroligin-1 
detects its ligand, neurexin-1β, in a complex biological mixture and at very low 
concentrations. In another test, to the brain extract was added purified recombinant 
neurexin-1β (Figure 16, lane B). This would serve as control for the procedure, in view of 
the fact that neuroligin-1 should be able to recognize its ligand from a complex biological 
mixture. Figure 16, lane C illustrate the proteins that were bound to an AChE-derivatized 
surface. As the results show, there was a lot of background binding to the flow channels, 
independent of the protein derivatized on the chip. Very few significant differences were 
observed between the 2 flow channels (see Figure 16A, B and C).  
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In conclusion, a pilot investigation was carried out using BIAcore analysis to establish 
if AChE interacts with proteins from a mouse brain extract. AChE was loaded onto a CM5 
chip. A brain extract was passed across the flow-cells containing AChE. Significant 
association was observed. However, the analysis of the bound material revealed 
background binding.  
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PART II: Screening for AChE interaction partners with the yeast  
      two-hybrid system 
 
The combination of surface plasmon resonance (SPR) with MALDI-TOF mass 
spectrometry (matrix assisted laser desorbtion/ionization time-of-flight) proved to be a good 
alternative for searching for AChE binding partners. The method does not raise the problem 
of using high amounts of purified protein like other biochemical approaches. In addition, a 
pre-clearing of the brain lysate by an affinity chromatography step with AChE immobilized 
on a column reduced the background binding in the surface plasmon resonance assay (not 
shown). However, the interactions happen in an in vitro assay, in buffers selected by an 
experimentator. Therefore, a genetic approach, namely yeast two-hybrid, was chosen to 
look for AChE binding partners. Yeast systems are generally intensely optimized and are 
closer to an in vivo system. 
 
3.2.1. AChE as bait for the yeast two-hybrid screen 
 
3.2.1.1. Cloning of the AChE constructs for the yeast two-hybrid screen 
 
To clone the bait into the pVJL11, a yeast vector that contains the LexA BD, a 
soluble, monomeric form of mouse acetylcholinesterase (mAChE), was used (Marchot et al., 
1996). This form, which was truncated at its carboxyl-terminal end, was generated from a 
cDNA encoding the AChE by insertion of an early stop codon at position 549. The cDNA 
contains the AChE exons 2, 3, 4, and 6, encoding the catalytic subunit of the mouse 
tetrameric and asymmetric form. 
Due to the fact that some proteins can activate the reporter genes in the yeast two-
hybrid system, several baits were constructed. Figure 17 shows the cloned AChE baits and 
the strategies used for cloning (PCR combined with restriction enzyme digestion and 
ligation). The approach was to create long AChE baits that cover extensive parts of the 
molecule, if not the entire AChE. It was shown that some cell adhesion molecules posses 
an ‘esteratic domain’, homologous to AChE. The homology to AChE was spread almost all 
over the molecule and not restricted to some short fragments (Cousin X. et al., 1997). 
Therefore, a long AChE fragment including the catalytic (aa 234, 365, and 478) and the 
peripheral anionic site was chosen as bait and named pVJL11-N583A (N – N-terminus, aa 
32-614, A-AChE), see Figure 17. Other shorter fragments (pVJL11-N472A, pVJL11-N263A, 
and pVJL11-C97A) were also cloned into the pVJL11 vector, with the intention to be used 
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later in order to identify the part of AChE involved in interaction. Before proceeding with 
actual screening, the chimeric cDNA was checked for mutations through sequencing. All the 
sequence data showed no mutation of the AChE fragments and therefore, they were used 
as bait to screen a mouse brain cDNA library. 
 
 
 
 
 
Figure 17. Cloning and sequence analysis of bait AChE. (A) The ACHE comprises 6 exons: 
exon 1 is not translated, exon 2 has 1068 bp, exon 3 - 485 bp, exon 4 – 170 bp, exon 5 – 665 bp, 
and exon 6 – 328 bp. (B) The AChE cDNA used was 2116 bp length and the ORF was translated 
into a 581 aa long protein. (C) The bait constructed for the screening was the N-terminal 583 aa 
fragment of AChE (aa positions 32-614) derived from AChE cDNA and cloned in-frame with the LexA 
DNA binding domain (LexA BD) in the vector pVJL11 and named pVJL11-N583A (aa 32-614). Three 
plasmids encoding C- or N-terminally truncated baits were also constructed: pVJL11-N472A (aa 32-
504), pVJL-N263A (aa 187-450), and pVJL11-C97A (derived from restriction and ligation of cDNAs 
or generated by polymerase chain reaction using a Pfu- proof reading DNA polymerase and primers 
that give the desired restriction sites). The sequences of all constructs were confirmed by 
sequencing.  
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3.2.1.2. Testing the Bait for auto-transactivation of the reporter genes (LacZ) 
 
Since the yeast two-hybrid system is based on reconstitution of a functional 
transcription factor, testing the auto-activation capacity of the AChE is crucial for the overall 
feasibility. Approximately 5% of all proteins have some latent activating activity (Criekinge 
and Beyaert, 1999) and randomly generated fragments (like in libraries) even more so. 
Thus, the constructed BD-AChE fusion proteins were transformed into the L40 yeast strain 
and tested for the activation of the HIS3 and LacZ reporter genes. 
The activation of the HIS3 was tested by growing the transformed yeast on DO/-Trp/-
His plates. The lack of Trp in medium allowed just the growth of the yeast cells hosting the 
expression plasmid, and the lack of His allowed just the growth of the transformed yeast 
cells that were able to activate the reporter gene HIS3. A weak activation of HIS3 was 
present on all the generated constructs in the form of a background growth. This growth 
was inhibited by adding 2.5 mM 3-AT (3-amino-triazole), a competitive inhibitor of the HIS3 
gene product. The amount of 3-AT necessary to inhibit the background growth was 
optimized by testing 3-AT concentrations between 1mM up to 15mM in medium. The lowest 
concentration that allowed after one week only small colonies to grow was 2.5 mM 3-AT, 
and therefore was further used for the screening. One has to consider that the use of too 
high concentrations could inhibit also the growth of the weak AChE interactors. 
None of the fusion constructs activated the second reporter gene - LacZ (see Figure 
18). The fusion constructs were transformed into the L40 strain either alone or together with 
a vector that contains the AD of Gal4 (pGADGH). In this manner, it was tested if the 
construct alone is activating the reporter genes, or if the construct it is somehow binding to 
the Gal4-AD and through this binding activates the LacZ gene. A pair of two known 
interactors, RalV23 and RLIP, served as positive control of the assay (Jullien-Flores et al., 
1995). The negative control was the transformation with the empty yeast two hybrid vectors 
pVJL11 and pGADGH. When transformed in yeast, the two vectors express independently 
the LexA BD and the Gal4 AD, but the two domains of the transcription factor fail to find 
each other in order to activate the reporter genes. 
The longest construct (pVJL11-N583A) was chosen to be used for the screen. 
However, the shorter constructs also did not have trans-activating properties (see Figure 
18B and C) and therefore were used later in the study to define the interaction site on 
AChE. 
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A 
 1 Positive control (+)            2                                        3                                        4 Negative control (-)RalAV23 and RLIP        pVJL11-N583A            pVJL11-N583A + pGADGH                  pVJL11 + pGADGH  
 
B 
1 Positive control (+)               2                                             3                                   4 Negative control (-) 
RalAV23 and RLIP        pVJL11-N472A            pVJL11-N472A + pGADGH                pVJL11 + pGADGH  
 
 
C 
1 Positive control (+)                2                                         3                                      4 Negative control (-) 
RalAV23 and RLIP        pVJL11-N263A           pVJL11-N263A + pGADGH                pVJL11 + pGADGH  
 
 
 
 
 
Figure 18. Test for the activation of the LacZ reporter gene of the constructed baits. 
The figure shows the results of X-Gal filter lift assay with yeast harboring different plasmids. (A), (B), 
(C) Lanes 1 show the positive control, RaLV23 and RLIP, a pair of two interacting proteins. The blue 
color is given by the hydrolysis of the X-Gal substrate by the β-galactosidase (the LacZ gene 
product). (A), (B), (C) Lanes 4 show the negative control of the assay, yeast cells transformed with 
the pVJL11 vector (encodes for LexA BD) and the pGADGH vector (encodes Gal4 AD). (A), (B), (C) 
lane 2 presents yeast colonies transformed with the constructed baits pVJL11-N583A, pVJL11-
N472A, and pVJL11-N263A, respectively, and tested for the activation of the LacZ gene. (A), (B), 
(C) lanes 3 shows yeast colonies transformed with pairs of pGADGH and pVJL11-N583A, pVJL11-
N472A, or pVJL11-N263A, respectively. No activation of the LacZ gene was observed for any of the 
3 bait constructs. 
Results 
 
67
3.2.1.3. Control of expression of the hybrid proteins in yeast 
 
To verify that the absence of auto-activating properties was not due to the lack of 
cDNA or fusion protein, the presence of cDNA and the expression of the fusion protein 
inside yeast were tested by colony PCR and Western Blot, respectively (see Figure 19). 
PCR done with yeast colonies transformed with pVJL11-N583A, using the mouse 
AChE specific primers EcoRI AChE – Pst I 2060 and EcoRI AChE - Sph I 1790, 
respectively, showed the presence of a 1040 bp and 678 bp product (see Figure 19A). The 
PCR products had the expected size, confirming that the yeast was transformed with the 
pVJL11-N583A. Western Blot was made with protein extracts from the L40 yeast 
transformed with pVJL11-N583A. Western analysis showed that the goat polyclonal 
antibody anti mouse AChE (raised against a peptide mapping at the N-terminus of mouse 
AChE) recognized a ~ 75 kDa protein (see Figure 19B). This was a bit higher than the 
predicted molecular weight. However, the hybrid protein might be migrating more slowly, 
and therefore have a higher apparent molecular weight in SDS-PAGE gels. The antibody 
did not recognize the shorter construct pVJL11-N472A (not shown). This might be due to 
the incorrect folding of the protein or a masking of the epitope.  
PCR and Western Blot showed that the AChE DNA and the protein are present in 
yeast. Therefore, the pVJL11-N583A construct can be used to screen a cDNA library for 
AChE interaction partners. 
 
3.2.2. Two-hybrid screen for AChE interaction partners 
 
3.2.2.1. Characterization of the MATCHMAKER mouse brain cDNA library 
 
A general rule for choosing a library is to select one prepared from a tissue in which 
the target protein (here AChE) is known to be biologically relevant. In this case an adult 
mouse brain library was chosen (Clontech). The cDNA library was cloned in the pACT2 
vector, which contains the Gal4 activating domain (GenBank accession no: U29899) into 
XhoI/ EcoRI cloning sites. The number of library independent clones was 3.5X106, the 
average cDNA size was 2.0 kb, and the estimated % of colonies with inserts was 95%. The 
number of colonies with inserts given by the producer was tested by randomly picking 100 
colonies, isolating the plasmid DNA and doing a restriction analysis. 62% of colonies had an 
insert. The library titer was determined by plating different library dilutions on LB-Amp 
plates, counting the colonies and using the producer’s formulas. The calculated titer was 
0.335x109 cfu/ml (cfu- colony forming units). 
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Figure 19. Confirmation of the DNA presence and protein expression in the 
transformed yeast. (A) 10 µl of the PCR reaction were separated on a 1% agarose gel and 
visualized with ethidium bromide under UV. Lane 1 and 2 show the presence of a specific PCR 
product with the calculated size. (B) Western blot analysis of yeast cell protein extracts. Proteins 
were separated with SDS-PAGE on a 7.5% gel and transferred to nitrocellulose membrane prior to 
immunodetection with an anti-mouse AChE antibody. Lane 1 is the negative control, a cell protein 
extract from yeast not transformed with the pVJL11-N583A. Lane 4 shows the positive control, a ~ 
75 kDa protein (68 kDa is the un-glycosylated form), present in the HEK 293 cell lysate (transfected 
with an expression vector encoding for AChE). Lanes 2 and 3 show a protein that has about the 
same molecular weight as the positive control (estimated MW was about 61kDa for the AChE plus 
the Lex A fragment).  
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3.2.2.2. Screening for interaction partners of AChE - Library transformation  
 
All the tests (auto-transactivation and protein expression) showed that the fusion 
LexA-AChE could be employed as bait in a two hybrid screen using the L40 yeast strain 
(see 3.2.1.2. and 3.2.1.3.). However, the L40 showed a basal expression of HIS3 reporter 
gene. This expression was inhibited by adding 2.5 mM 3-AT in the yeast growth medium. 
The bait AChE and the library were sequentially transformed into the yeast, which means 
the cDNA library was transformed into the L40 yeast strain that already hosts the bait 
plasmid pVJL11-N583A. The idea of a successful screen is to saturate the screening to 
obtain as many transformants as possible, and to avoid transformation of a single yeast cell 
with multiple library plasmids, which can seriously complicate subsequent analysis. The 
employment of the sequential transformation gives better results for such a screen. Two 
independent library transformations were made, using the LiAc method (see 2.2.2.4.). This 
method typically results in transformation efficiencies of 106 transformants per mg of DNA 
when using a single type of plasmid. Approx. 2X106 transformants were screened in these 2 
experiments. The transformants were plated out on DO/-Leu/-Trp/-His plates that are 
selective for the two plasmids and the additional auxotrophic reporter gene HIS3. The plates 
included also 2.5 mM 3-AT. After 5-6 days growth at 30°C the first colonies were picked. 
The size of the colony was considered to reflect the strength of the interaction, the bigger 
the colony is, the stronger is the interaction. However, the small colonies should not be 
considered background. Due to the high number of colonies that grew, just 190 big and 
middle size colonies were further analyzed. The transactivation of the second reporter gene 
LacZ was tested by analyzing β-galactosidase activity using the β-galactosidase filter assay 
described in 2.2.2.5. Most of the positive clones chosen to be further analyzed turned blue 
within 5 hours at 30°C. 
 
3.2.2.3. Checking the potential positive clones - insert analysis, assay of the 
specificity in the yeast two-hybrid system 
 
A large fraction of the 190 His+ colonies showed no blue color with the β-
galactosidase filter assay, and therefore they were not further analyzed. 96 colonies 
displayed β-galactosidase activity (see Figure 20). In order to control the presence and size 
of the library cDNA, yeast colony PCR with pACT2 specific primers was performed (see 
2.2.1.10. for protocol). Due to the big size of the library inserts, these PCRs were not 
yielding to the complete amplification of the library cDNA. Therefore, the plasmid DNA was 
isolated from all 96 HIS+/LacZ+ colonies (see 2.2.2.7.) and electroporated into E. coli strain 
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HB101. These yeast minipreps contained both the bait and the library hybrid plasmid. Thus, 
the HB101 strain was used. HB101 had a defect in the leuB gene, which could be 
complemented by the LEU2 gene from yeast vectors. These bacteria, when grown on M9 
selective medium, selected just for the library plasmids (Leu+). Library plasmid was 
subsequently isolated from yeast and analyzed by restriction enzyme digestion. This 
digestion showed that a small part of library plasmids had no insert. Figure 20 gives an 
overview of the screen and shows the results of the intermediary steps. 
 
   2 million yeast transformants screened 
 
 
      190 His+
 
 
         96 His+/LacZ+
 
 
      60 had an insert 
 
 
     23 pVJL11-N583A-dependent His+/LacZ+ 
 
Figure 20. Summary of the yeast two-hybrid screen for AChE interacting proteins. 
Yeast strain L40 was transformed with pVJL11-N583A and selected for Trp prototrophy. These yeast 
cells were transformed with a mouse brain cDNA library cloned into the pACT2 vector. Yeast 
cotransformants containing putative AChE interacting partners were selected by growth on minimal 
medium lacking Trp, Leu and His. The His+ clones were tested for the β-galactosidase activity and 
96 showed activity. 60 of the library fusions were shown to contain a cDNA library insert. 23 of the 
library plasmids were found to produce β-galactosidase activity only when cotransformed with 
pVJL11-N583A, but not when cotransformed with the control fusion plasmids pVJL11-LexA-Lamin 
and pVJL11-LexA-p53. 
 
Because many clones obtained from the yeast two-hybrid screen are false positives, it is 
essential to test the interaction of the individual pACT2-Gal4-cDNA clones with the pVJL11-
N583A and with an unrelated protein such as lamin and p53. Therefore, before sequencing, 
all the library fusions were retransformed in yeast in the following combinations: 
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• alone, in order to see whether they have autoactivating properties, 
• with the empty vector pVJL11, 
• together with the pVJL11-N583A (to re-test the interaction found by screening), 
• and together with pVJL11-lamin or pVJL11-p53. 
 
Figure 21 shows an overview of the β-galactosidase activity assay for all the yeast two-
hybrid positives. 
 
3.2.2.4. Prey overview 
 
Much more information about the prey was derived from sequence data. The identity 
of the AChE interacting proteins was determined by sequencing directly from the pACT2 
vector using standard automated DNA sequencing methods. The derived cDNA sequences 
were analyzed using blastx. A search for homologues proteins in all the reading frames was 
done. The results are presented in Table 1. The reading frame of the sequenced DNA was 
compared with the ORF of the pACT2 vector. The listed names of the clones (Table 1) are 
in conformity with the pACT2 ORF and represent the smallest blastx eValue result. By 
analyzing the obtained sequences, it was possible to classify inserts into two main groups; 
those of potential interest, and the others. Some proteins can also be excluded from the list 
of interesting interactors if they are part of a list of known false positives that are frequently 
found, independently of the target used (e.g. Zn-finger proteins, hsp, ribosomal proteins). 
In conclusion, screening a brain cDNA library for AChE-interaction partners proved to 
be a successful method. At the end of the control procedures 23 clones were identified as 
‘true’ positives. The proteins encoded by these clones are binding partners of 
acetylcholinesterase in yeast. 
 
 
 
 
 
(next page) Table 1. Overview of the AChE potential binding partners. β-Galactosidase 
activity was determined by filter lift assay for the L40 strain cotransformed with the indicated 
plasmids. +++, ++, + represent colonies that turned strongly blue, moderately blue, and weakly blue, 
respectively; - represent colonies that did not turn blue after 5 hours incubation. The homologies 
represent the blastx search that gave the smallest eValue. The clone numbers with the same colour 
represent fragments that are either identical, or belonging to the same protein.  
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LacZ test after the retransformation in 
combination with Clone 
# 
Growth 
on DO/-
His 
LacZ Test 
  - pVJL11 pVJL11-AChE 
pVJL11-
Lamin 
pVJL11-
p53 
 Homologies 
8  +  +  - -  +  -  - 
unknown mouse cDNA, 
no homologies 
10  +  +  - -  ++  -  - mouse septin 
12  +  +++  - -  +  -  - mouse laminin beta 1 
13  +  +  - -  +  -  - 
Siat7f protein, 
sialyltransferase 
20  ++  +  - -  +  -  - 
mouse DNA from clone 
RP 23 143 
23  ++  +  - -  +  -  - rabphilin 3A 
24  +  +  - -  ++  -  - unknown cDNA 
29 
 +  +++  - -  +  -  - 
N-acetyllactosaminide 
alpha-1,3-
galactosyltransferase 
33  +  ++  -  -  +  -  - 
mouse DNA from clone 
RP 23 143 
43  +  +  - -  +  -  - 
Protein kinase beta 
subunit 
47  +  +  -  -  +  -  - 
mouse DNA clone RP 23 
- 56 on chromosome 18 
50  + +  +  - -  +  -  - 
mouse DNA from clone 
RP 23 415c3 
55  +  +  - -  +  -  - 
mouse DNA from clone 
RP 23 143 
56  +++  ++  - -  ++  -  - 
mouse DNA from clone 
RP 23 354 K2 
58 
 +  +  - -  +  -  - 
mouse DNA from clone 
RP 23/actin gamma 
cytoplasmic 
60  +  +  -  -  +  -  - mouse Tbk1 
62 
 ++  ++  - -  +  -  - 
adult male cerebellum 
cDNA, hypothetical Zn-
finger CChC type 
containing protein 
63  +  +  - -  +  -  - 
mouse DNA clone RP 23 
- 56 on chromosome 18 
70  +  +  - -  +  -  - 
mouse embryo 12 days 
DNA 
78  +  ++  - -  +  -  - mouse creatine kinase 
88 
 ++  +  - -  +  -  - 
mouse, similar to HBx 
Ag transactivated protein 
2 
91  ++   +  - -  ++  -  - mouse creatine kinase 
96  +  +  - -  ++  -  - mouse Tbk 1 
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 β-Galactosidase filter lift assay with the „putative“ AChE-interaction partners, part 1 
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F
p
a
t
oβ-Galactosidase filter lift assay with the „putative“ AChE-interaction partners, part 2 
igure 21. β-Galactosidase filter lift assay with the „putative“ AChE interaction 
artners. Shown are L40 yeast cells that were transformed with different combinations of AD (Gal4) 
nd BD (LexA) fusion proteins. An interaction between a fusion protein pair will give a blue color of 
he filter. The protein pairs that do not interact are, depending on the color of the yeast colony 
range-yellow, pink or white. 
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PART III: AChE interacts with laminin-1β  
 
3.3.1. AChE – laminin-1 interaction in the yeast two-hybrid system 
 
A laminin fragment of 898 bp (see Figure 23) was found as interacting with AChE in 
a yeast two-hybrid screen using as bait the full length core AChE (583 aa). After sequencing 
the clone, computational analysis was done with NIH-blastn and blastx (from PubMed 
website), see Table 2. By screening 2X106 clones, the laminin-1β chain appeared once as 
AChE putative-interaction partner. To confirm the interaction, the laminin fragment was re-
transformed in yeast together with the pVJL11-N583A and tested for the activation of the 
LacZ reporter gene (Figure 22). To determine the possible binding site of AChE on laminin-
1, two shorter LexA-AChE constructs were transformed together with pACT2-Laminin into 
L40 yeast strain. Figure 22 shows that the intensity of the signal in the β-galactosidase test 
decreased with the length of the construct. The shorter construct, pVJL11-N263A, activated 
weakly the LacZ gene.  
The data indicated that in the view of the results of the β-galactosidase filter lift 
assay, the interaction between AChE and laminin-1 is moderately strong and that the region 
containing 240th aa residue to 503th aa residues of AChE is essential for interaction with 
laminin-1β.  
 
 
 
 
Blastx result eValue Identity 
laminin B1 subunit 1 [Mus musculus] e-178 98% 
Laminin beta-1 chain precursor (Laminin B1 chain) e-178 98% 
similar to laminin B1 [Rattus norvegicus] e-175 98% 
laminin, beta 1 precursor [Homo sapiens] e-168 92% 
laminin, beta 1 [Danio rerio] e-128 72% 
 
Table 2. The results of the blastx alignments for the clone 12.  
Results 
 
76
 
 
 
          G  C  R  P  C  D  C  D  L  G  G  A  L  N  N  S  C  S  E  D  S  G  
ctcgagatgggtgtcgaccttgtgactgtgaccttggaggggcgctgaacaatagctgctccgaggactccggc 
 
Q  C  S  C  L  P  P  M  I  G  R  Q  C  N  E  V  E  S  G  Y  Y  F  T   T  L   
agtgctcctgcctgccccccatgattgggcggcagtgtaacgaggtggagtccggttactacttcaccaccctg  
 
C  D  H  Y  I  Y  E  A  E  E  A  N  L  G  P  G  V  V  V  V  E  R  Q  Y  I  
gaccactacatctacgaagccgaggaagccaatctggggcctggagtcgttgtggtggaaaggcagtacattcag 
 
Q  D  R  I  P  S  W  T  G  P  G  F  V  R  V  P  E  G  A  Y  L  E  F  F  I  
gaccgcattccttcctggacaggacctggcttcgtccgggtgcctgaaggggcttatttggagtttttcattgac 
 
D  N  I  P  Y  S  M  E  Y  E  I  L  I  R  Y  E  P  Q  L  P  D  H  W  E  K  
aacataccatattccatggagtatgaaatcctgattcgctatgagccacagctgccggaccactgggagaaagct 
 
A  V  I  T  V  Q  R  P  G  K  I  P  A  S  S  R  C  G  N  T  V  P  D  D  D  
gtcatcactgtacagcggccggggaagattccagccagcagccgatgtggtaacaccgttcccgatgatgacagc 
 
S  Q  V  V  S  L  S  P  G  S  R  Y  V  V  L  P  R  P  V  C  F  E  K  G  M  
caggtggtgtccttgtcaccgggctcaagatacgttgtcctccctcgccccgtgtgctttgagaagggaatgaac 
 
N  Y  T  V  R  L  E  L  P  Q  Y  T  A  S  G  S  D  V  E  S  P  Y  T  F  I  
tacacggtgaggttggagctgccccagtatacggcatcgggcagtgacgtggagagcccttacacgttcatcgac 
 
D  S  L  V  L  M  P  Y  C  K  S  L  D  I  F  T  V  G  G  S  G  D  G  E  V  
tcgcttgttctcatgccctactgtaaatcgctggacatcttcactgttggcggctcaggcgatggggaggtcacc 
 
T  N  S  A  W  E  T  F  Q  R  Y  R  C  L  E  N  S  R  S  V  V  K  T  P  M  
aatagtgcctgggaaaccttccagcgctacaggtgtctggagaacagcaggagtgtggtaaaaacacccatgaca 
 
T  D  V  C  R  N  I  I  F  S  I  S  A  L  I  H  Q  T  G  L  A  C  E  C  D  
gatgtctgcagaaacattatcttcagcatttctgccttgattcaccagacgggccttgcttgtgaatgtgacccc 
 
P  Q  G  S  L  S  S  V  C  D  P  N  G  G  Q  C  Q  C  R  P  N  V  V  G  R  
cagggatctctgagttctgtgtgtgaccccaatggaggccagtgccagtgccgtcctaatgtggttggaagaacc 
 
T  X  N  
tncaaca 
 
 
Figure 23. Nucleotide and amino acid sequence of clone 12, corresponding to mouse 
laminin-1beta. The open reading frame is+3. The sequence starts with the XhoI restriction site. 
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Figure 22. Interaction of AChE constructs with laminin-1beta on L40 yeast. Shown are 
the β-galactosidase activity test results. Blue: interaction, white: no interaction. On the right side 
there is a schematic alignment of the AChE constructs used. 
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3.3.2. AChE interacts with laminin 1 – confirming the interaction through 
coimmunoprecipitation experiments 
 
After finding that laminin-1 binds to AChE in the yeast two-hybrid system, it was 
important to see a confirmation of the interaction outside the yeast cell. To such end, 
several assays are available, such as in vitro “pull-down” assays and 
coimmunoprecipitation. As already mentioned, AChE is a glycoprotein and has intrachain 
disulfide bridges. A pull-down assay was from the beginning not suitable, because the 
system is based on expression of fusion-proteins in bacteria. Data until up to now showed 
that in bacteria AChE will be expressed in an inactive form and accumulated in inclusion 
bodies (see Heim et al., 1998). Therefore, a coimmunoprecipitation assay was chosen. 
 
2 different approaches were made (see also Figure 24): 
• by using an anti-mouse AChE (goat polyclonal) or an anti-mouse Laminin (rabbit 
polyclonal, rat monoclonal) antibody, to coimmunoprecipitate laminin, respectively 
AChE from mouse brain membrane protein extracts; 
• AChE was overexpressed in the HEK293 cell line by transfection with pCDNA3-
AChE, and laminin-1 was added as protein (purchased from Sigma) into the cell 
lysate. The same antibodies mentioned above were used. 
 
L A                                                B 
AChE
Figure 24. Experimental design for the coimmunoprecipitation of AChE and Laminin. 
(A) An antibody against N-terminus of AChE was used to co-immunoprecipitate laminin-1 from a 
brain extract or cell lysate. The antibody-AChE-laminin-1 complex was isolated with the help of 
Protein G-Sepharose. (B) An antibody against laminin-1 was used to co-immunoprecipitate AChE. 
Protein G-Sepharose was used to isolate the antibody-laminin-1-AChE complexes. L- Laminin. 
Protein 
G 
AChE 
Protein
G 
L
AChEL L
L AChE
Anti-
AChE 
Anti-
Laminin 
IgG IgG 
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From the 3 antibodies available, 2 were shown to immunoprecipitate the protein: the 
goat polyclonal anti-AChE could precipitate AChE from a brain extract (Figure 25A), and the 
rabbit polyclonal anti-laminin-1 could precipitate laminin-1 (Figure 25A, lane 3). The rat 
monoclonal anti-laminin did not seem to bind to laminin-1 and was not further used (Figure 
25A, lane 2). HEK293 cells were transfected with an AChE expression vector (pCDNA3-
AChE). AChE activity was measured in both brain extracts (~ 4.6 mU/ mg protein) and HEK 
293 cell lysates (~5.5 mU/mg). The first attempts to coimmunoprecipitate AChE and laminin 
from the brain extracts were not successful. This may be also due to the high salt – 
detergent buffer used to solubilize the membrane proteins (1 M NaCl, 0.5% Triton X-100). 
The buffer was then changed by dialysis with PBS, 0.1% Triton X-100. After dialysis the 
AChE activity decreased generally by 1 mU. 
Figure 25B and 25C shows that using the goat polyclonal anti-AChE laminin-1 was 
coimmunoprecipitated with AChE, both from brain extract or HEK293 cell lysate, when 
these extracts were “spiced” with 5 µg laminin-1 (Sigma). The rabbit polyclonal anti-laminin 
was not able to coimmunoprecipitate AChE and laminin. The results of the Coomassie 
staining showed a band corresponding to the ~70 kDa AChE (Figure 25B, lane 3), but 
Western analysis revealed no AChE signal. Also, the binding seemed to be dependent on 
buffer salt concentration. From the 4 different coimmunoprecipitation buffers, PBS with 0.1% 
Triton X-100 gave the best results. No binding was observed in buffers containing 500 mM 
NaCl, 250 mM NaCl and 200 mM NaCl. 
 
The summarized results are the following: 
• The anti-mouse AChE could precipitate together with AChE (from brain extracts or 
HEK293 transfected cell extracts) laminin-1, when the amount of laminin-1 in the 
extracts was increased by adding 5 µg purified laminin-1. 
• The anti-mouse laminin-1 gave contradictory results. The antibody could precipitate 
laminin-1 and also AChE from the HEK293 cell lysates (Coomassie gel staining 
showed a band corresponding to the AChE MW). No AChE band was present in the 
Western Blot experiment, making these results not consistent. 
• The AChE – laminin-1 binding is inhibited by high salt concentration in the buffer 
(from 500 mM NaCl to 200 mM NaCl). The best results were obtained by using as 
binding buffer PBS + 0.1% Triton X-100. 
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Figure 25. Laminin-1 binds to AChE in vivo – coimmunoprecipitation experiments. (A) 
shows Coomassie stained 7.5% SDS-PAGE gels. Laminin (lane 1) appears as 2 bands on the gel, a 
400 kDa band (the alpha 1 chain) and a 200 kDa band (beta and gamma chains). A monoclonal anti-
laminin-1 antibody didn’t precipitate laminin 1 (lane 2). A polyclonal anti-laminin-1 antibody could 
immunoprecipitate laminin-1 (lane3). The polyclonal anti-AChE antibody bound to the AChE (A), 
right. (B) After immunoprecipitation with an anti-AChE or anti-laminin antibody the proteins were 
separated on a 7.5% gel and the gel was stained with Coomassie. Using an anti-AChE antibody both 
AChE and laminin-1 were immunoprecipitated from brain extracts (B) left or from HEK293 cell 
lysates (B) right lane 1 and 2, respectively. The 200 kDa band corresponds to the laminin-1beta and 
gamma chains. (C) Western analysis with an anti-laminin antibody of the AChE 
coimmunoprecipitated proteins. 
Results 
 
81
3.3.3. Co-localization of AChE and laminin-1 in the central nervous system 
 
To determine whether AChE is localized in the same region as laminin-1 in the CNS, 
immunofluorescence microscopy and Karnovsky-Roots histochemistry studies were done. 
20 µm thick adult mouse brains sections were stained with a mixture of anti-mouse AChE 
and anti-mouse laminin-1 antibodies (see 2.1.16.) and analyzed under a fluorescence 
microscope. The brain sections were from adult mice 68 to 75 days old. Controls without the 
first antibody were carried out to ensure that the staining was specific. 
The fluorescence microscopy image of an adult mouse brain section reveals laminin-
1 staining throughout the nervous system. The stain appears to be confined to the blood 
vessels (see Figure 26A). Karnovsky-Roots cholinesterase activity staining shows that the 
CNS stained densely for AChE (Figure 26C) even if here the cholinergic innervation is 
limited. Figure 26B shows that the AChE can be found also concentrated in nuclei of 
activity. The antibody staining revealed that AChE was predominantly associated with the 
nerve cell bodies (Figure 26D), but also on the neurites (Figure 26G). As illustrated in Figure 
26F, laminin-1 was mostly present in blood capillaries or at the contact of capillaries with the 
glia cells. The presence of laminin-1 (EHS laminin; alpha1-beta1-gamma1) and AChE was 
examined in the CNS. The anatomy and morphology of AChE stained neurons has been 
examined extensively (Bolam et al., 1984; Ostergaard et al., 1992). The pattern of labeling 
was consistent with AChE localization described in the stereotaxic atlas and elsewhere 
using the AChE histochemical method. Laminin-1 is associated with the blood vessels. 
However, studies of the distribution of the laminin chains showed a different pattern. For 
instance, literature data reveal that immunostaining for gamma1 chain is present throughout 
the central nervous system (CNS) in essentially all neuronal cell bodies and their most 
proximal processes (Hagg et al., 1997).  
The results presented in Figure 26 together with the literature data show that AChE 
and laminin-1 are both expressed in brain and therefore provide support for a direct 
interaction of the two proteins. 
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Figure 26. Localization of AChE and laminin-1 in the mouse CNS. (A) Laminin-1 and 
DAPI staining on a mouse brain section. (B) and (C) represent Karnosky-Roots AChE activity 
staining. (D), (E), (F) represent the same brain section stained with an anti-AChE (D, red) and an anti 
- laminin-1 (F, green) antibody. (E) – DAPI staining of cell nuclei. (G) Double staining for AChE (red) 
and laminin-1(green). Scale bar 100 µm. 
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4. Discussion 
 
4.1. Neurexin-1β expression pattern overlaps with the AChE 
expression, but neurexin-1β does not bind to AChE 
 
In the first part of this study, I attempted to show that AChE competes with the 
homologous neuroligin to bind neurexin-1β.  
 
4.1.1. AChE and Neurexin-1β expression during retinal differentiation and 
synaptogenesis 
 
Neurexin-1β 
 
Within the vertebrate retina, non-catalytic neurogenic roles have been attributed to 
AChE based on the spatiotemporal pattern of its expression during development. The 
presence of the cholinesterase-like domains in the noncatalytic, cell adhesion proteins, e.g. 
neuroligin-1, may reflect the capacity of AChE for protein-protein interactions. Therefore, we 
addressed the question whether AChE competes with the cell adhesion molecule 
neuroligin-1 for the binding to its ligand neurexin-1β. 
Before answering this functional question, the expression of neurexin-1β was 
analyzed in the developing chicken retina with the help of in situ hybridization and compared 
with the AChE expression pattern. The staining appeared to be specific, as the hybridization 
with a control ‘sense’ probe gave no signal. It was shown that both neurexin-1β and AChE, 
two genes whose protein products are involved in neurotransmission, became detectable in 
differentiating chicken retinal cells much before the synaptogenesis. Indeed, their spatial 
expression patterns overlapped. Temporally, AChE expression (appearing first at E4) 
shortly precedes the neurexin-1β (first seen at E6). The neurexin-1β gene was first detected 
in the ganglion cell layer, followed by the expression in the inner half of the inner nuclear 
layer. This pattern remained constant during retinal development and was limited to the 
above mentioned layers. In the retina, ganglion cells are generally considered to be 
generated first; therefore it was predictable that the first neurexin-1β transcripts would be 
present in the ganglion cells. The first embryonic day where the neurexin-1 gene appeared 
was E6, corresponding to the stage of intense ganglion cell differentiation. The neurexin 
expression pattern superimposes the steps of retinal differentiation toward synaptogenesis. 
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The first neurexin signals appeared in the ganglion cell layer at the E6 when a vast majority 
of retinal cells are still proliferating, except for a part of ganglion cells that start to 
differentiate. At E9 when the retina is largely post-mitotic, but most of the cells remain 
morphologically undifferentiated, a specific pattern of expression became obvious and 
remained qualitatively unchanged at E13 and E19. During all retinal development the 
photoreceptors did not express neurexin-1β.  
Up to now, there are no published studies about the neurexin-1β expression in the 
retina. However, the results were not surprising considering the roles of neurexins. These 
proteins function as heterophilic cell adhesion molecules (Nguyen and Südhof, 1997) and 
can also affect the fusion of neurotransmitter vesicles with the plasma membrane (Sugita et 
al., 1999). The regulation of vesicle fusion, as well as cell adhesion may affect the 
progression of growth cones toward their targets as well as the transition from neurite 
extension to synaptogenesis. This neurexin expression pattern was comparable with the 
neurexin expression in developing mouse brain (Puschel and Betz, 1995). Transcripts of 
neurexins were detected in the mouse brain starting at E10 and increased with the 
maturation of the nervous system. RNAs of neurexins were found throughout the nervous 
system exclusively in postmitotic neurons (similar to the chick retina) and at least one day 
before synapses are formed. To date, this is the first study to report neurexin-1β localization 
in the retina.  
 
AChE 
 
AChE is considered a marker for differentiating retinal cells (Layer and Willbold, 
1995). When AChE was overexpressed in mice, an embryonic feedback mechanism 
drastically lowered the neurexin-1β transcripts in spinal cord neurons. This suggested that 
embryonic neurexin expression is concerted in vivo with the AChE levels (Andres et al., 
1997). To confirm this, AChE staining in the developing retina was undertaken. Similar to 
previous studies of this type (Layer et al., 1987), the staining confirmed the presence of 
AChE-positive cells in the ganglion cell layer, in the inner nuclear layer, and in 2 sub-bands 
in the inner plexiform layer. 
In the current study both the histochemical activity staining (Karnovsky-Roots), and 
the antibody staining with a monoclonal antibody against chicken AChE were used (Tsim et 
al., 1988). The AChE labeling appeared to be specific, since the omission of the first 
antibody significantly reduced labeling. When staining for AChE, most research groups use 
the histochemical method. Typically, histochemical methods can lead to non-specific 
labeling of all cholinesterases, since butyrylcholinesterase (the other cholinesterase) can 
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also hydrolyze acetylcholine. Therefore iso-OMPA, a specific inhibitor for the 
butyrylcholinesterase, was used for the histochemical staining. Antibodies have the 
advantage that they do not rely on the cholinergic activity of cholinesterases; therefore they 
can be raised against particular species of AChE and diluted to the required level for cellular 
labeling. Furthermore, within neurons there is non-activated AChE (Massoulie et al., 1993), 
which would be revealed by antibody staining but not by the Karnovsky-Roots method. 
However, AChE-stainings of chicken retina yielded similar results for both methods 
(enzymatic-light and fluorescent). 
The first AChE-positive cells were observed at E4 in the central part of the retina. 
This correlates with the hypothesis that the expression of AChE indicates one of the earliest 
postmitotic events in the life of differentiating neurons. Although very few amacrine cells 
would be cholinergic innervated, it appeared that a large population of cells from the 
ganglion cell layer and the inner nuclear layer express an active form of AChE. This might 
be attributed to the non-cholinergic, morphogenic role of the protein during retinal 
differentiation.  
The staining for AChE displayed the presence of the enzyme also in the synaptic 
inner plexiform layer, where the labeling appears in the form of two sub-layers from E13 
onwards. Stratification at the IPL level has been observed from about embryonic day E9. 
The first band is formed by cholinergic cells at E9 or E10, followed by a second cholinergic 
sub-band at E13. The retinal inner plexiform layer (IPL) is a highly organized synaptic zone, 
where visual information is transmitted from bipolar cells onto ganglion cells and is 
controlled and modified by amacrine cells through laterally interconnecting branches. Cajal 
(1972) previously established the existence of five sublayers in the vertebrate retina. The 
layers reflect zones where specific sets of cells interconnect. The development of these 
sub-layers is not well understood. However, the early presence of AChE-sublayers in the 
chicken retina, before synaptogenesis, suggests a non-cholinergic, pre-synaptogenetic role 
for AChE.  
 
From these labeling studies it was possible to conclude that: 
1. The spatial expression of neurexin-1β was correlated with the AChE in the chick 
retina. 
2. Temporally: the first neurexin-1β transcripts appeared 2 days later compared with 
AChE. 
3. The expression of both markers was intense during the differentiation of the neurons 
that send their axons and dendrites in the inner plexiform layer to form synapses 
(ganglion, amacrine and horizontal cells). 
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This distribution suggests that AChE supports the neurite outgrowth, while neurexin-1β 
could be involved in pathfinding and synaptogenesis in the retina. Unfortunately, double 
stainings were not done for the AChE and neurexin-1β, so it is impossible to claim that the 
same cell population was labeled with these two different markers. However, mouse AChE 
shows no binding to neurexin-1β at concentrations up to 100-fold above where neuroligin-1 
binding to neurexin-1β can be demonstrated (Comoletti et al., 2003). The absence of AChE 
binding does not appear to be a consequence of the different glycosylation pattern on 
AChE, because a glycosidase-treated AChE also shows no detectable neurexin-1β binding 
(Comoletti et al., 2003). Nevertheless, as already mentioned, these results do not exclude 
the possibility that AChE binds to different neurexin isoforms in other experimental systems.  
 
4.1.2. Expression patterns of other retinal markers 
 
The Expression of Synaptotagmin I precedes synaptogenesis and correlates with 
neurexin-1β expression 
 
The adhesion function of neurexins is explained by its binding to neuroligin. The 
second already mentioned function of neurexins, the regulation of neurotransmitter vesicle 
fusion with the plasma membrane, implies another interaction, which is the binding of 
neurexin’s intracellular domain to synaptotagmin I (Hata et al., 1993). Synaptotagmin, a 
major intrinsic membrane protein of synaptic vesicles, interacts with the cytoplasmic domain 
of neurexins; the binding is calcium-independent and of moderate affinity. To confirm that 
neurexin-labeled neurons are also synaptotagmin-positive, the expression pattern of 
synaptotagmin I in the chicken retina was analyzed with in situ hybridization.  
Synaptotagmin I mRNA was expressed in the ganglion cell layer starting with the E6. 
The early expression of synaptotagmin can not be explained by their classical role as 
synaptic vesicle proteins, since the first steps of synaptogenesis in the inner plexiform layer 
take place about E12 (Sheffield and Fishman, 1970). At E9, not just GCL, but also the inner 
nuclear layer displayed synaptotagmin I signals. This pattern remained constant throughout 
the retinal development and paralleled the neurexin-1β expression in the chick retina.  
The expression of these two markers in the retina can be correlated with processes 
of presynaptic differentiation. The presynaptic active zone is created through the assembly 
of elaborate macromolecular complexes (Garner et al., 2002). These processes can easily 
take place in small cells, e.g. epithelial cells, but the neuron’s morphology creates unique 
trafficking and sorting problems. One of the ways to solve this problem is the generation of 
precursor vesicles and the early maturation of synaptic vesicles. Before synaptogenesis, the 
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non-regulated fusion of these vesicles at non-synaptic sites leads to detectable levels of 
neurotransmitter along the growth cones (Hannah et al., 1999). The contribution of the 
released neurotransmitter to the synaptogenesis is unknown. However, this mechanism can 
explain why synaptotagmin I was expressed immediately after axon outgrowth. The protein 
could be a resident of heterogeneous organelles that probably represent a mixture of 
precursors for synaptic vesicles and the axon plasma membrane. 
 
Neurofilament M transcripts are present solely in the retinal ganglion cells 
 
Neurofilaments are nerve cell specific intermediate (10 nm) filaments. Together with 
actin microfilaments and microtubules they form the cytoskeleton of neurons. Three distinct 
polypeptides are constituents of the neuronal 10 nm-filaments, the NF-L, NF-M, and NF-H 
proteins. Expression of the NF-M gene appears to be correlated with projection length and 
arborization of neurons (Zopf et al., 1987).  
An in situ hybridization with a neurofilament M riboprobe revealed labeling in the 
chicken retina starting with the E6. The labeling was constantly distributed in cells of the 
GCL. The neurofilament M-labeled cells may be ganglion cells or displaced amacrine cells. 
Neurofilament antibody staining was used extensively by other groups to visualize ganglion 
cells and their axons in the retina of different vertebrate species (Straznicky et al., 1992; 
Kong and Cho, 1999). By using other ganglion cell markers, it has been reported that the 
staining was exclusively limited to the ganglion cells. However, the expression of 
neurofilament may not represent a commitment to a ganglion cell phenotype (Fischer et al., 
2002). Bennett and DiLullo (Bennett and DiLullo, 1985a, 1985b) reported that also 
neuroepithelial and neuroblastic cells of the chick central nervous system express 
neurofilament proteins and that some of this expression is transient. The results of the in 
situ hybridization together with the literature data suggest that neurofilament M is expressed 
exclusively by the ganglion cells in the chicken retina, and therefore can be used as a 
ganglion cell marker. 
 
Tyrosine hydroxylase 
 
It is known that the dopaminergic neurons of the central nervous system release a 
large proportion of AChE. Using double fluorescent labeling it was established that in the 
CNS nearly all the dopaminergic neurons were labeled for AChE, and in addition there were 
non-dopaminergic but AChE-positive neurons (Henderson and Greenfield, 1984). In the 
retina, the distribution of the dopaminergic neurons was already documented. However, the 
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distribution of TH mRNA in the retina was not documented. Therefore, in situ hybridization 
with a TH riboprobe was done. The first TH-positive cells in the retina were identified at E12. 
These cells were located in the INL, next to the INL-IPL border. At E19 the TH-positive cells 
were placed at the border of INL with IPL, an observation consistent with previous studies. 
Kagami and co-workers reported that using a monoclonal or a polyclonal antibody against 
chicken tyrosine hydroxylase, the first labeled cells appeared at E11 (Kagami et al., 1991). 
The phenomena of migration of TH-positive cells toward INL-IPL border was described with 
the help of antibody staining.  
 
 
 
Figure 27. Scheme of the temporal and topographical distribution of AChE, neurexin-
1β, synaptotagmin I and neurofilament M gene transcripts in the developing chicken 
retina. Cells from the ganglion cell layer were labeled with an AChE riboprobe starting at E4, and 
with neurexin, synaptotagmin and neurofilament riboprobes from E6 onwards. Cells of the inner 
nuclear layer express AChE, neurexin, synaptotagmin mRNA from E6 onwards; they did not express 
neurofilament M. 
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4.1.3. Surface plasmon resonance and mass spectrometry-based AChE “ligand 
fishing” 
 
Two approaches were used to search for unknown AChE binding partners. A first 
approach was the use of surface plasmon resonance technology combined with mass 
spectrometry to identify and characterize novel AChE binding partners. Several groups 
demonstrated that the BIAcore technology can be successfully used to isolate and identify 
target molecules from a complex biological mixture (Zhokov et al., 2002). The method was 
applied to AChE bound to the surface of the flow cells of a sensor chip. A brain membrane 
extract was injected over these flow cells and the material bound to the flow cells (AChE) 
was recovered in a small buffer volume. However, this procedure is far from being 
established for the use in proteomics. The initial experiments demonstrated considerable 
nonspecific binding to the surfaces of the flow system. This complicated a subsequent 
analysis by mass spectrometry. Therefore, a genetic approach was favored over the 
biochemical system.  
 
4.2. AChE-binding partners revealed in a yeast two-hybrid screen 
 
4.2.1. Is AChE suitable for use in a yeast two-hybrid screen? 
 
The yeast two-hybrid system was developed to identify genes encoding proteins that 
are physically associated with a given protein in vivo (Song and Fields, 1989). However, the 
two-hybrid system does not provide a solution for all protein - protein problems. For different 
experimental reasons, as discussed below, some proteins are not considered to be suited 
for this approach.  
A major disadvantage of assaying protein-protein interactions in any heterologous 
system is that some interactions depend upon posttranslational modifications that do not, or 
inappropriately, occur in yeast. Such modifications include the formation of disulfide bridges, 
glycosylation and most commonly phosphorylation. This was also the case for AChE, which 
is an extracellular glycoprotein with three disulfide bridges. The two-hybrid system was 
predicted to be limited to the analysis of cytoplasmic proteins. Indeed, extracellular proteins 
are often N-glycosylated and contain disulfide bonds, both of which are not expected to 
occur in the yeast nucleus. Nevertheless, several successes were reported with 
transmembrane receptors. Appropriate extracellular receptor-ligand interactions were 
demonstrated for the growth hormone, prolactin and growth hormone releasing receptors 
(Young and Ozenberger 1995; Kajkowski et al., 1997). These studies provided basis for the 
Discussion 
 
90
decision to use AChE as bait for screening a cDNA library. The AChE binding partners 
found should however be seen in a critical way, since the protein would not be glycosylated 
and the interaction would be mainly depending on its primary structure.  
Another obvious point of concern for the system relates to the extensive use of 
chimeras. The use of artificially made fusion proteins always implies a potential risk. The 
fusion might change the actual conformation of the bait and/or prey and consequently 
modify their functions. This misconformation might result in a limited activity or in the 
inaccessibility of binding sites. However, the use of tagged proteins in general has been 
very successful in many biotechnological approaches. This success might rely on the fact 
that protein domains can fold rather independently, enabling the co-existence of different, 
even artificially introduced, modules in the same protein. 
Since the two-hybrid system makes use of a transcription event, one of the most 
crucial initial experiments was to check whether AChE was able to initiate transcription. If 
this is the case, it might seriously handicap the successful use of this protein in any two-
hybrid approach. The LexA-AChE hybrid protein showed no activation of the reporter genes 
HIS3 and LacZ, and therefore could be used for screening.  
The two-hybrid system needs the fusion proteins to be targeted to the yeast nucleus. 
This might be a disadvantage for extracellular proteins or proteins that contain strong 
targeting signals. To avoid secretion of AChE, the 33 aa signal peptide of AChE was not 
included in the construct used for screening. However, rat AChE was previously 
successfully expressed in yeast (Pichia pastoris), the purified protein having properties 
comparable with the native AChE. The expressed AChE had a molecular weight of 67kDa 
(native AChE has 69kDa) suggesting a glycosylation and the same inhibition properties 
(Heim et al., 1998). Western blots of L40 yeast cells transformed with a plasmid encoding 
the LexA-AChE hybrid protein showed the presence of a 75kDa protein recognized by an 
anti-mouse AChE antibody. Only homogenates of yeast cells collected in the logarithmic 
growth showed signals in Western Blot analysis with an anti-AChE antibody. These results 
could be explained by the nature of pVJL11 vector promoter. The normally very strong 
alcohol dehydrogenase 1 (ADH1) promoter in the pVJL11 vector is truncated to 410bp, and 
expression from this truncated promoter leads to low expression levels of fusion protein 
(Tornow and Santangelo, 1990). 
My preliminary tests indicated that the AChE did not activate the HIS3 and LacZ 
reporter genes and was expressed in yeast as fusion with LexA-BD. Therefore, the AChE 
construct was used as bait in a yeast two-hybrid screen to search for interaction partners. 
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4.2.2. AChE ligands in the yeast two-hybrid system 
 
The core of AChE (present in all the molecular forms of the enzyme, aa 33-583) was 
used to screen a mouse brain yeast two-hybrid library. 190 colonies were found to be HIS3 
positive. From this, just 96 could activate the second reporter gene LacZ. Previous studies 
showed that most of the HIS3+/LacZ- colonies were no ‘in-frame’ fusions and carried non-
fused downstream genes encoding transcription factors (James et al., 1996). Since all 
combinations of protein-protein interactions are assayed, the possibility of identifying 
artifactual partners exists, and it is a typical disadvantage of all exhaustive screening 
procedures. Of 96 HIS3+/LacZ+ clones, 23 were identified as ‘true’ AChE binding partners in 
the yeast two-hybrid system. Insert analysis was performed first. From 96 clones just 60 had 
a library insert. The remaining 60 clones were retransformed with positive and negative 
controls to assay the specificity of the interaction. These included cotransformation of the 
detected prey with the empty vector (containing LexA-BD) or with a vector encoding an 
irrelevant protein (p53 and lamin). Further false positives were identified, e.g. library cDNAs 
that activated the reporter genes by itself, or ‘sticky’ fragments that could interact with the 
control proteins p53 and lamin. One of the yeast two-hybrid pitfalls is the high number of 
false positives. However, it was possible to partly eliminate them by a series of additional 
transformations and testing the reporter gene activity.  
More information was gained by sequencing the prey cDNA. Analysis of sequences 
revealed other possible false positives. This category included all known genes that are not 
in frame with the activation domain and those with unknown genes that show a polyAAA tail 
indicating that the gene is probably inverted. Other genes that might be omitted from further 
analysis do not encode proteins but RNA. Some proteins can also be excluded if they are 
part of a list of known false positives that are frequently found, independently of the target 
used. This list includes hsp's, ribosomal proteins, cytochrome oxidase, mitochondrial 
proteins, proteasome subunits, ferritin, tRNA synthase, collagen-related proteins, Zn-finger 
proteins, vimentin (from the web site of E. Golemis 
http://chaos.fccc.edu/research/labs/golemis). 
The AChE interaction partners identified in the yeast two-hybrid screen were classified in 
two main categories and are listed below: 
 
1. Unknown cDNAs: unknown mouse cDNA, no homologies; mouse DNA from clone 
RP 23 143 (3X); mouse DNA clone RP 23 - 56 on chromosome 18 (2X); mouse DNA 
from clone RP 23-415c3; mouse DNA from clone RP 23-354 K2; mouse DNA from 
clone RP 23/actin gamma cytoplasmic; mouse embryo 12 days DNA. 
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2. Known proteins: mouse septin; mouse laminin beta1; Siat7f protein, 
sialyltransferase; rabphilin 3A; N-acetyllactosaminide alpha-1,3-
galactosyltransferase; protein kinase beta subunit; mouse Tbk1 (2X); adult male 
cerebellum cDNA - hypothetical Zn-finger CChC type containing protein; mouse 
creatine kinase (2X); mouse, similar to HBx Ag transactivated protein 2. 
Figure 28 presents an overview of the screen results and the ligand localization. The 
basis for protein sequence alignments was provided by the open reading frame of the 
vector. One of the advantages for databases research was the work with mouse proteins, 
as extensive information was available about the mouse genome. Only the homologous 
proteins from mouse were considered and further analyzed. Nevertheless, the results of a 
database research should be carefully interpreted, also because the clones did not include 
full-length DNAs.  
 
 
48%
33%
19%
unknow n DNAs
cytoplasmic proteins
Membrane,
transmembrane proteins
 
 
Figure 28. Schematic 
representation of the yeast 
two-hybrid screen results. 
 
 
 
 
 
 
Although the choice of which interactions to characterize further is arbitrary, some 
guidelines were used. For new proteins that show no homology with any known sequence in 
DNA or protein databases, the above selection becomes less trivial. As general criterion, 
the redundancy at which the interaction is found is considered to be a clue for the 
importance of the interaction. For known proteins, the potential biological relevance of the 
interaction is the most important criteria. 
Table 3 summarizes the known proteins found as AChE ligands in the yeast two-
hybrid screen, together with their localization, functions, and possible relevance of the 
interaction.  
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Name of AChE 
ligand 
Subcellular 
localization 
Function Biological relevance 
of the interaction 
Adult male cerebellum 
cDNA; hypothetical Zn-
finger CChC type 
containing protein  
• nucleus Nucleic acid-binding protein Often present in the list of 
false positives 
Creatine kinase • cytoplasm 
• mitochondria 
Energy and metabolism, 
phosphotransferase 
? 
Protein similar to HBx 
(hepatitis B virus protein 
X) Ag transactivated 
protein 2 
• nucleus 
• cytoplasm 
Transcriptional transactivator, 
activation of signal 
transduction pathways 
List of false positive 
Laminin-1 beta • extracellular 
matrix 
Cell growth, differentiation, 
neuron migration, growth, 
morphology, and adhesion, 
Relevant 
N-acetyllactosaminide 
alpha-1,3-
galactosyltransferase 
• membrane of 
Golgi trans 
cisternae 
Enzyme EC 2.4.1.87 Glycosylation of AChE? 
protein kinase beta 
subunit 
• cytoplasm Signaling pathways Other researchers could 
show an AChE-PK co-
regulation. Direct binding? 
Rabphilin 3A • cytoplasm 
• attached to 
synaptic 
vesicles 
Binds to rab3a which is a GTP-
ase that mediates directional 
vesicular trafficking and 
regulate synaptic vesicle 
exocytosis 
? 
Septin • presynaptic 
vesicles 
membranes,  
GTPase enzyme, required for 
the cytokinesis stage of cell 
division and for exocytosis 
? 
Sialyltransferase • membrane of 
Golgi 
apparatus,  
• endoplasmic 
reticulum 
Cellular communication and 
signal transduction 
Glycosylation of AChE? 
Tbk1 • cytoplasm, 
• translocated to 
nucleus 
Triggers the host antiviral 
response to viral infection 
? 
 
Table 3. Yeast two-hybrid AChE ligands: localization, function, relevance of the interaction. 
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 Another factor that has to be considered after the analysis of sequences is the 
possibility of the two proteins to find each other in the natural environment. Table 3 presents 
the localization of these ligands in the cell. Due to the so-called time/space constraints it is 
potentially possible that both proteins, although able to interact, are never in close proximity 
to each other within the cell. The two proteins could be expressed in different cell types, or 
even when found in the same cell they could be localized in distinct subcellular 
compartments. Moreover, interacting proteins can be expressed at different points during 
embryogenesis or during homeostasis (e.g. at different time points in the cell cycle). So 
once two interacting partners are identified, the biological relevance of this interaction 
remains to be determined. 
 
4.2.2.1. Unknown cDNAs - new proteins 
 
Interestingly, 48% of the prey obtained by screening a yeast two-hybrid library with 
AChE was represented by unknown cDNA sequences. The analysis of these sequences is 
more difficult compared with the known proteins and raised interpretation problems due to 
the lack of an adequate amount of information. Nevertheless, the unknown clones will 
certainly give rewarding outcomes. As already mentioned, the frequency at which the 
interaction was found might be a clue for the importance of the interaction. This was the 
criteria that allowed a primary selection. Important to mention is that this frequency is not 
related to the strength of the interaction. With new proteins, it was difficult to find parts of the 
coding sequence. By performing extensive database searches, and using multiple 
sequence alignment algorithms, one can sometimes reconstitute full-length cDNA clones 
(using FASTA and blastn). Using these sequence data, one can perform many different 
algorithms to predict subcellular localization, transmembrane domains, conserved functional 
patterns, etc. This could be done with PROSITE (USA) and PROPSEARCH at EMBL. 
However, the attempts to reconstruct full length cDNA or to identify motifs were not very 
successful. Of course, such predictions are never ‘direct’ evidence, but could be the starting 
point for more conclusive experiments.  
In this study, the analysis of the potential AChE interaction partners was limited to 
known proteins mostly because these proteins were less problematic to investigate. 
However, the novel proteins that interact with AChE can prove to be more fascinating and 
bring new insights into the adhesion function of AChE.  
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4.2.2.2. Cytoplasmic proteins 
 
AChE is an extracellular soluble or membrane bound protein. A majority of 33% from 
the known proteins identified as binding partners for AChE were localized intracellularly (see 
Table 3). Taken together, these facts would suggest that the cytoplasmic proteins should be 
considered as ‘false positives’. Indeed, a classification of potential protein – protein pairs 
based on known function or location is normally used as a criterion to decrease the number 
of false positives in a yeast two-hybrid system. It is usual to avoid further studies of 
combinations that are unlikely to colocalize in vivo. There are exceptions, however, in which 
some proteins may move to different parts of the cell, where they may interact with other 
proteins.  
Surprisingly, it was observed that under stress conditions, mice produced the rare 
read-through AChE splice variant and this variant accumulated in neuronal cell bodies 
(Birikh et al., 2003). This came unexpected, considering the existence of a signal peptide on 
the nascent AChE and the generally secretory nature of this protein. Moreover, Ye and 
colleagues (Ye et al., 2001) could show that nascent polypeptides targeted for ubiquitin-
dependent processing and destined for secretion may be released from the rough 
endoplasmic reticulum into the cytoplasm. Soreq and co-workers suggested that under 
stress the intracellular compartmentalization could be altered, and thus AChE could also 
appear intracellularly. However, there is no experimental evidence available to support this 
and it should be still considered as a speculation. 
Secondly, like other glycosylated membrane and secreted proteins, AChE is 
synthesized at the level of rough endoplasmic reticulum and translocated into the lumen 
where their signal peptides are cleaved. The enzyme is first synthesized as inactive 
precursor, acquiring activity in the reticulum (Hassig et al., 1991). Only a fraction of the 
enzyme is transported towards the cell surface, a large proportion of AChE subunits, either 
active or inactive, are degraded in non lysosomal compartments (Massoulie et al., 1993). 
One can consider that part of this inactive AChE precursor is released into the cytoplasm 
and accounts for the interaction with cytoplasmic proteins. 
The intracellular AChE binding proteins could be classified as follows: 
 
1. Transcription factors - A hypothetical Zn-finger CChC-type containing protein and a 
protein similar to HBx (hepatitis B virus protein X) Ag transactivated protein 2 
 
These two proteins are involved in processes related to transcription events, and are 
localized in the nucleus. One of the most important and better understood types of 
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transcription factors are zinc finger proteins The Zn-finger motif is often present in proteins 
that bind nucleic acids. HBx is also transcription transactivator. Transcription factors appear 
often in the lists of yeast two-hybrid screen false positives, due to their ability to bind and 
activate gene promoter elements. Therefore, these two proteins were considered to belong 
to the list of false positives. 
 
2. Synaptic proteins - Rabphilin 3A and septin 
 
Some of the cytoplasmic proteins identified in the yeast two-hybrid screen, e.g. 
rabphilin 3A and septin, are proteins involved in synaptic functions like vesicle trafficking 
and exocytosis (Hsu et al., 1998; Fung and Scheller, 1999; Hsueh et al., 2000).  
Rabphilin 3A was the first identified rab3a effector (Shirataki et al., 1993) binding to 
rab3a through its N-terminus (Schlüter et al., 1999). Rab3a is a member of a large family of 
low molecular weight GTPases that is localized to synaptic vesicles, and is thought to 
mediate directional vesicular trafficking and regulate synaptic vesicle exocytosis. Rab3a 
cycles between an active, GTP-bound form and an inactive, GDP-bound form, which is 
dependent upon the accumulation of rabphilin 3A which stabilizes the GTP-bound form of 
rab3a on the vesicle (Hsueh et al., 2000). Rabphilin 3A binds also to CASK, a scaffolding 
protein. CASK binds to Mint-1 and Veli-1 forming a presynaptic multicomplex involved in the 
recruitment of channels and receptors to the neurexin-1β & neuroligin-1 complex at the 
forming synapses (Zhang et al., 2001).  
The septins are a family of GTPase enzymes, some of which are required for the 
cytokinesis stage of cell division and others for exocytosis. Nine mammalian septins have 
been found, however only G-septin is found to be phosphorylated. Nedd5 is a brain specific 
septin and its phosphorylation increases in response to stimulation with cyclic nucleotides in 
nerve terminals. Nedd5 immunoprecipitated with the SNARE protein syntaxin by directly 
binding to syntaxin via the SNARE interaction domain. These data suggest that septins may 
regulate vesicle dynamics through interactions with syntaxin (Beites et al., 1999). In mice 
and humans, 12 septin genes generate dozens of polypeptides that form hetero-oligomeric 
filamentous complexes. These filaments, which organize higher-order structures by self-
assembly and templated assembly, are regarded as the functional units of the septin 
cytoskeletal system (Kinoshita et al., 2002).  
How does AChE get in contact with rabphilin 3A or septin? As mentioned, AChE can 
appear intraneuronally under stress conditions. During periods of cell differentiation or 
synaptogenesis, many of the synaptic components are synthesized long before they 
become functional. It is confirmed that these components can actively contribute to 
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synaptogenetic steps and are recruited from cytoplasmic pools (Garner et al., 2002). AChE 
is present very early in developing neurons and secreted into the extracellular space. 
However, during these early developmental steps, the synaptic secretory machinery is far 
from being well organized. One can consider that during these intense activity steps not all 
the proteins, e.g. AChE, reached their classical subcellular localization or functions. With 
AChE present in the neuronal cytoplasma, an interaction between AChE and raphilin3a or 
septin will raise interesting possibilities that AChE might be involved in synaptic vesicle 
dynamics. Electron microscopy studies of subcellular localization of AChE in the post-mitotic 
neurons are required in order to establish whether this model can be confirmed. Co-
immunoprecipitation experiments would also enable to determine if the binding appears 
outside the yeast system. Another possibility is that the existence of some structural motifs 
on the proteins may be responsible for this interaction. However, there is the possibility that 
the interaction of AChE with rabphilin 3A and septin in a yeast two-hybrid system could be 
the result of a forced colocalization of the proteins in the same cellular compartment. 
Nevertheless, AChE is not the sole extracellular protein found to interact with septin. Other 
extracellular proteins, e.g. sip1, were identified as binding partners for septin in yeast two-
hybrid screens (Giot et al., 2003). 
Figure 29 summarizes the model in which cytoplasmic AChE, via binding to 
rabphilin3A or septin may modulate synaptic vesicle dynamics on developing neurons.  
 
Figure 29. Schematic drawing of the synaptic AChE binding partners. Rabphilin 3A and 
septin are pre-synaptic proteins connected to synaptic vesicles and involved in vesicle trafficking. 
AChE is membrane bound or secreted, but can be also localized cytoplasmatically, and therefore 
may interact with rabphilin3a and septin. 
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3. Kinases – Tbk1 kinase, protein kinase-β and Creatine kinase 
 
There are accumulating data that show a connection between cholinesterases and 
kinase pathways. Therefore, the yeast two-hybrid results regarding kinases are very 
promising. AChE is shown to interact with the scaffolding protein RACK and through it, with 
its target, protein kinase C-βII (Birikh et al., 2003). Moreover, an overexpression of AChE 
through transfection studies lead to an increase in the expression of protein kinase C (Keller 
et al., 2001). As already mentioned, AChE is related to processes of neuronal 
differentiation, neurite outgrowth and synaptogenesis. Kinases are well established players 
involved in processes like proliferation, differentiation, and apoptotic cell death.  
Three different kinases were found to interact with AChE in yeast: TANK-binding 
kinase, protein kinase A and creatine kinase. TANK-binding kinase is a protein that 
mediates the TANK’s ability to activate NF-kB (Pomerantz and Baltimore, 1999). NF-kB is a 
ubiquitously expressed transcription factor that regulates the induction of genes involved in 
immune and inflammatory cell function (Verma et al., 1995). Not too much is known about 
the roles of the TANK-kinase during development of the nervous system.  
Creatine kinase is an enzyme involved in energy metabolism in brain and muscle. It 
was revealed that migrating neuronal growth cones exert traction forces that are generated 
by ATP-driven F-actin/myosin interactions. Sustained generation of these forces requires an 
energy supply mediated by the guanidino kinases, creatine kinase and arginine kinase 
(Wang et al., 1998). Creatine kinase is a key ATP-generating enzyme that regulates ATP 
within subcellular compartments. It could be possible that creatine kinase is bound to AChE 
where it may provide bursts of site-specific high-energy phosphate necessary for 
developmental processes, e.g. efficient receptor signal transduction during cytoskeletal 
reorganization. 
The interaction of AChE with a third kinase, the beta subunit of a cAMP-dependent 
protein kinase A seems more pertinent at the neuromuscular junction. This due to the 
accumulating data that show a connection between cAMP and AChE levels at the junction. 
Tsim and co-workers showed that in the developing neuromuscular junctions, the regulation 
of muscle AChE expression can occur by two mechanisms: factors secreted from the 
presynaptic neuron during synaptogenesis and muscle intrinsic factors during myogenesis 
(Siow et al., 2002). Their results suggested that muscle intracellular cAMP is one of the 
candidates to regulate the expression of AChE during early myogenic differentiation. The 
activation of intracellular cAMP synthesis is mediated by a cAMP-dependent protein kinase 
(PKA) and a cAMP-responsive element-binding protein (CREB) (Choi et al., 2000). The 
decrease of cAMP may be a signal to trigger the differentiation process such as the 
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induction of muscle-specific genes that includes the expression of AChE. By binding to 
AChE, the cAMP-dependent protein kinase would be a sensor for AChE concentrations and 
regulate its own expression.  
 
4.2.2.3. Membrane proteins  
 
N-acetyllactosaminide alpha-1,3-galactosyltransferase and sialyltransferase  
 
The two enzymes are transmembrane proteins found in the trans-cisternae of Golgi 
apparatus. These proteins present enzymatic functions and are involved in processes of N-
glycosylation. AChE is a glycosylated protein, though the functions of the glycoparts are 
largely unknown. An affinity of AChE to these enzymes is therefore to imagine. 
Galactosyltransferase catalyzes the transfer of galactose from UDP-galactose to an 
acceptor molecule using manganese as cofactor. Sialyltransferase catalyzes the 
polycondensation of alpha-2,8-linked sialic acid required for the synthesis of polysialic acid, 
a modulator of the adhesive properties of neural cell adhesion molecule (N-CAM1). The 
encoded protein, which is a member of glycosyltransferase family 29, is a type II membrane 
protein that may be present in the Golgi apparatus.  
In conclusion, the yeast two-hybrid screen revealed that AChE binds to enzymes that 
are involved in glycosylation, one of the AChE maturation processes. We can interpret this 
as a transient interaction of the inactive AChE polypeptide that appears in Golgi apparatus. 
 
4.3. Laminin-1 interacts with AChE 
 
Using a yeast two-hybrid screen, we were able to identify an 898 bp fragment of 
laminin-beta1 chain as interaction partner of AChE in yeast. Co-immunoprecipitation was 
used to confirm the interaction between laminin-1 and AChE. The β-galactosidase filter lift 
assay data indicated that the interaction between these two proteins is moderately strong 
and that the region containing 240th aa residue to 503th aa residues of AChE is essential 
for interaction (the numbers include the 32 aa of the signal peptide). However, when 
transformed in yeast together with laminin-1 beta, the AChE construct lacking the catalytic 
serine 234 showed a weaker activation of the LacZ reporter gene than the constructs that 
included Ser 234. That the catalytic serine is not important in the interaction came not 
surprisingly. It was already demonstrated, using specific catalytic site inhibitors, that the 
developmental functions of AChE e.g. neurite outgrowth and differentiation are independent 
of its enzymatic activity. Johnson and Moore previously reported that human AChE binds to 
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mouse laminin-1 (Johnson and Moore, 2003). A significant reduction in the binding was 
observed when peripheral anionic site inhibitors (fasciculin, propidium, BW284c51) were 
used. Fasciculin, a 61 aa peptide, reduced AChE binding to laminin-1 close to zero. 
Therefore, it was proposed that the binding occurs at the peripheral anionic site of the 
enzyme (Johnson and Moore, 2003). The yeast two-hybrid results indicate that by partially 
disrupting the structure of the peripheral anionic site, the interaction appears to become 
weaker. However, studies with AChE mutants of the amino acids that comprise the 
peripheral anionic site are necessary for determining if the peripheral anionic site is directly 
involved and which amino acids are essential for interaction.  
The coimmunoprecipitation studies indicated that the interaction was also highly 
dependent on the NaCl concentration used in the interaction buffer. High ionic buffers (250 
mM to 500 mM NaCl) did not allow binding of these two proteins. These results confirm the 
observations of Johnson, 2003, indicating that an electrostatic mechanism may be involved 
in binding. Electrostatic complementarities between interacting proteins has been found to 
be one of the major driving forces for complex formation (McCoy et al., 1997). Examination 
of the 3-D structure of AChE showed the enzyme to be characterized by a marked 
asymmetric spatial distribution of charged residues, which were shown to roughly segregate 
into a ‘northern’ negative hemisphere and a ‘southern’ positive one (Ripoll et al., 1993). The 
asymmetric distribution of surface potentials was thought to be essential for the fast 
catalysis of AChE. However, it has been shown that the role of surface potential in catalysis 
is only minor (Felder et al., 1997). It was proposed that the surface potentials are related to 
other functions than catalysis, e.g. adhesion (Botti et al., 1998). Analysis of the sequence 
alignment of AChE, neuroligin, neurotactin, gliotactin showed no sequence motif shared 
exclusively by these proteins. Thus, it was concluded that the above mentioned proteins are 
the members of a class of adhesion molecules that, because of their common electrostatic 
motif, are named electrotactins (Botti et al., 1998). Therefore, the high interaction 
dependence of the salt concentration supports a contribution of an electrostatic mechanism 
to the interaction.  
Which is the site of interaction on laminin-1? It is known that laminins are fibrillar 
glycoproteins. Figure 30 shows that laminin-1 is a heterotrimeric protein composed by α1-, 
β1-, γ1- chains, with the three chains forming a cruciform structure. The short arms of the 
cross-like structure are represented by the N-terminal regions of the three chains, while the 
long arm is a coiled structure of the C-terminal regions that holds them together.  
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Figure 30. Domain structure and 
interaction sites of laminin-1. The laminin 
fragment possibly interacting with AChE is 
marked.  
 
 
 
 
 
 
 
 
 
A single fragment comprising 898 bp of laminin-beta1 chain was found to interact 
with AChE. The fragment is located closer to the N-terminal region of the chain and includes 
the globular domain IV (see Figure 30). The N-terminal regions of the laminin chains are 
heterogeneous, consisting of alternating globular and cysteine-rich domains of varying size 
and number (Tunggal et al., 2000). The β1 chain includes two globular domains named IV 
and VI (Figure 30). The N-terminal globular domain VI of the β1 chain is important in laminin 
polymerisation (self-assembly) (Yurchenco et al., 1992) and the globular domain IV has no 
specific function. Utani et al., (1997) reported that fibulin-2, an extracellular matrix 
glycoprotein, binds to the globular domain IV on the chain γ2. The globular domains 
alternate with non-globular domains V and III. These domains are formed of 3-8 LE 
modules, rich in cysteine (8 residues) and homologous to epidermal growth factor. The 300 
aa of the laminin-beta1 fragment identified by yeast two-hybrid screening comprises the 
globular domain IV and part of the domain III. With respect to which site on laminin-1β might 
interact with AChE, it is likely that the globular domain mediates this binding. 
The binding of AChE to laminin-1 clarifies the AChE postulated role of an adhesive 
molecule during development. It is reported that laminin-1 binds to different integrin 
receptors like α2β1, α3β1, α7β1, α6β4 (Teller and Beaulieu, 2001). Integrins comprise a 
large family of cell adhesion molecules that mediate interactions between the extracellular 
environment and the cytoplasm. The cytoplasmic domains of integrins interact with 
microfilaments. Therefore, integrins link the cytoskeleton to the extracellular matrix. The site 
of this interaction between microfilaments and the extracellular matrix is called a focal 
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contact. These focal contacts provide the strength necessary for the cell to arrange the 
extracellular matrix by pulling on it. In addition, the focal adhesion sites are the location of 
an activated enzyme called focal adhesion kinase. FAK is a tyrosine kinase that appears to 
be activated by certain integrins. Thus, integrins are a very important way of promoting 
signal transduction in the cell. Integrins can stimulate other signaling receptors as well. 
Despite the large amount of indirect experimental evidence supporting the 
involvement of AChE in adhesion processes, no evidence was provided to support this. 
Here we propose a model for the developmental function of AChE, based on its interaction 
with laminin-1. The most likely mechanism through which AChE sends signals into the cell is 
the following: during development, the early secreted AChE binds to laminin-1β (see Figure 
31). Laminin-1β is expressed very early and ubiquitously during development. The laminin-
1β mRNA was first detected at two or four cells stage (Dziadek and Timpl, 1985) and the 
mouse laminin-1 protein first at the morula stage (Cooper und MacQueen, 1983). Laminin-1 
binds to integrin receptors, a class of cell adhesion molecules known to be involved in 
neuronal migration during CNS development, most likely by mediating the adhesive 
interactions between neurons and radial glial fibers. It is well established that cell adhesion 
molecules such as integrins play an important role in building and maintaining synaptic 
structure during CNS development (Benson et al., 2000). Integrins activate the ERK 
activation cascade (Ras -> Raf -> MEK -> ERK) via a focal adhesion kinase mechanism 
(see Figure 31). In the CNS the kinase involved is named pp125FAK.  
Such a mechanism was proposed for transglutaminase, a cell surface glycoprotein 
with enzymatic activities that also promotes adhesion independent of its enzymatic activity 
(Akimov et al., 2000). Transglutaminase binds both fibronectin and β1-integrins promoting 
integrin clustering and intracellular signal activation.  
Thus, the intracellular effect of AChE would consist of exerting changes in signaling 
pathways, and via remodeling of cytoskeletal structures.  
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Figure 31. Proposed model for AChE signaling. AChE binds to the laminin-β1 chain and 
through laminin-1 can enhance the activation of integrin receptors. Integrins, as adhesion receptors, 
are able to send signals into the cytoplasm and via FAK activate intracellular signaling pathways. 
ECM-Extracellular matrix, FAK-focal adhesion kinase, MAPK-mitogen activated protein kinase, PI3-
phosphatidylinositol-3 kinase.  
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4.4. Future work 
 
The studies on binding partners of AChE present many opportunities for future 
experiments. The challenge for future studies is to demonstrate the biological significance of 
these interactions.  
A primary goal of future research should be to determine whether the proteins found 
as AChE binding partners in a yeast two-hybrid screen interact with AChE also in a 
biochemical system. Once the interaction is confirmed in a biochemical way, the kinetic 
parameters of the binding (kD) and the part of the proteins involved in interaction would be 
determined.  
For the unknown proteins a first step would be to clone the entire sequence of the 
gene by screening a mouse cDNA library and RACE-PCR, then computer-base analyze the 
characteristics of the encoded protein, and study its expression pattern with in situ 
hybridization. After determining the molecular properties of the protein, their binding to 
AChE would be analyzed. Tagged constructs (His, IgG, etc) or antibodies against the new 
proteins would be generated for coimmunoprecipitation experiments.  
A further advance would be to determine the significance of the interaction in the cell. 
This will require disrupting the interaction of the two proteins (siRNA, antisense transfection 
for AChE) and assessing the subsequent effects on AChE functions, such as adhesion. A 
future task will be to unravel in detail the molecular cascades involved. Detailed studies of 
the Ca++- or cAMP-mediated signaling pathways components under modified AChE 
expression will be helpful in further elucidating the cholinesterase signaling. 
Although these studies represent a challenge, they are likely to result in rewarding 
advances in the field of AChE research. 
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5. Summary 
 
Acetylcholinesterase (AChE) is the enzyme that hydrolyses the neurotransmitter 
acetylcholine at the cholinergic synapses. Besides this principal role, called the classical function, 
AChE shows also other non-classical functions related to processes during embryonic 
development and diseases. The existence of multiple molecular forms, the homology with other 
neuronal cell adhesion molecules, and the early expression pattern, suggest that AChE may 
function in cell adhesion, and thus in neurite growth, guidance and even synaptogenesis.  
To gain an insight into the noncholinergic, cell adhesion promoting functions of 
acetylcholinesterase, we sought proteins interacting with it. Since AChE is mostly an 
extracellular or membrane- attached molecule, the binding partners for AChE should be: 
expressed in the same tissues and at the same developmental stages as AChE, have both 
an extracellular and an intracellular domain connected through one or more transmembrane 
domains, and possibly be able to initiate an intracellular signaling cascade. 
Due to the 34% sequence identity between AChE and neuroligin-1, a neuronal cell 
adhesion molecule, we postulated that the neuroligin’s binding partner, neurexin, may bind 
to AChE. Initially, we had to show that the AChE binding partner is expressed in the same 
tissues and at the same time with AChE. The pattern of expression of neurexin-1β and 
AChE was analyzed in the chicken retina using in situ hybridization. The results show that 
AChE-positive cells in the retina also coexpress neurexin, with AChE preceding neurexin 
(~48h). Both are strongly expressed long before synaptogenesis, which starts about 
embryonic day 13 in the chicken retina. Their expression profiles are consistent with the 
hypothesis that the neurexins and AChE have a function in early neuronal differentiation 
and axonogenesis. However, no specific neurexin-1β binding to AChE was evident using 
surface plasmon resonance (Comoletti et al., 2003). 
In the second part of the work, a yeast two-hybrid screen was initiated aimed at 
identifying novel proteins that interact directly with AChE. 2X106 clones from a cDNA mouse 
brain library were screened with a bait containing exons 2, 3 and 4 from ACHE mouse gene. 
190 His positive clones were identified and from these clones 96 were also positive on β-
galactosidase test. The plasmids were isolated, re-transformed in E.coli, and controlled for 
the presence and size of the cDNA insert. From 96 clones, we thereby identified 23 prey 
clones that 1) grew well on histidine-free plates and displayed strong β-galactosidase 
activity, when coexpressed with the bait, and 2) showed no interaction with the reporter 
genes in coexpression with LexA binding domain or with control fusions lamin-LexA binding 
domain and p53-LexA binding domain. This strongly suggested that the proteins encoded by 
these clones are binding partners of acetylcholinesterase in yeast.  
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Sequencing of the cDNA inserts of the clones identified 18 independent candidates: 
7 are unknown proteins and 11 are already known mouse proteins. From the 11 known 
mouse proteins, 4 were membrane and extracellular proteins, 2 were transcription 
activators, 2 were synaptic proteins and 3 were kinases. Due to its subcellular localization, 
structure and functions, we first focused on showing that laminin is binding to AChE in 
another system than yeast.  
Confirming the interaction between AChE and its binding partners outside yeast is 
the first step after a screen. By a yeast two-hybrid approach, we identified an interaction 
between the AChE and an 898 bp fragment of laminin-beta1 chain, an extracellular matrix 
protein involved in neuronal differentiation and adhesion processes. The yeast two-hybrid 
data indicated that the interaction between these two proteins is moderately strong and that 
the region containing 240th amino acid residue to 503th amino acid residues of AChE is 
essential for interaction. The interaction was confirmed by co-immunoprecipitation assays. 
In addition, the co-immunoprecipitation showed that the binding was highly dependent on 
the NaCl concentration used in the interaction buffer. These results confirm the 
observations of Johnson (Johnson and Moore, 2003), indicating that an electrostatic 
mechanism may be involved in binding. This led to the model in which AChE is binding to 
laminin-1 during early developmental stages. Laminin-1 interacts with integrin receptors 
(Teller and Beaulieu, 2001) and is so able to send signals into the cell modulating signaling 
cascades.  
Taken together, the results of this present study suggest a role for AChE in 
heterophilic adhesion. Understanding this role will bring a major progress in the field of non-
classical functions of AChE.  
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APPENDIX 
 
Transmembrane 4 superfamily, member 2 (tetraspanin) 
 
CCCCNCCAAACCCAAAAAAAGAGATCTCTATGGCTTACCCATNCCATGTTCCAGATTACGCTAGCT
TGGGTGGTCATATGGCCATGGAGGNCCCGGGGNATCCGAATTCGCGGCCGCGTCGACATCGAGGAG
AATGGAGACCAAACCTGTGATAACCTGTCTCAAAACCCTCCTCATCATCTACTCCTTCGTCTTCTG
GATCACTGGGGTGATCCTGTTGGCCGTTGGAGTCTGGGGAAAGCTGACTTTGGGAACCTATATCTC
CCTGATTGCTGAGAACTCCACAAATGCTCCCTATGTGCTCATTGGAACCGGCACCACCATCGTGGT
TTTTNGTCTCTTTGGATGCTTTGCTACATGCCGTGGTAGTCCATGGATGCTGAAACTGTATGCCAT
GTTCCTGTCCCTGGTGTTCCTGGCTGAGCTTGTTGCTGGCATTTCTGGATTTGTGTTTCGTCATGA
GATCAAGGACACCTTCCTGAGGACTTACACGGNATGCCATGCAGAACTACAATGGCAATGATGAGA
GGAGCCGGGCTGTGGACCATGTGCAGCGCAGCCTGAGCTGCTGTGGCGTGCAGAACTACACCAACT
GGGAGCAGCAGCCCCTACTTCCTGGAACCATGGCATCCCCCCCCAGTTGCTGCATGAACGAAACTG
ACTGCAATCCCCCTGGATCTGCACAATCTGACTGTGGCCGNCCACCAAAGTTAATCAGAANGGCTG
GTTATGATCTGGGTGAACAAGGTTTTTTGGAAAACTAACATGGGGNATCATTTGCTGGGNGNGGNA
TTTGGNANTNGCGTTCTA 
 
Rabphilin 3A  
 
TNNGNTGNTGNAGATACCCCACCAAACCCAAAAAAAGAGATCTCTATGGCTTACCCATCCCNTGT
NCCAGATTACGCTAGCTTGGGTGGTCATATGGCCATGGAGGNCCCGGGGATCCNAATTCGCGGCC
GCGTCGACCGGGTCCGGTGCAACGAGCAGAGGCGCCGCCCGCCGGGAATGTGAACGAAGAGCCAC
CGGCCGCGCCGCAACCGGGTCGGTGCCGATTTGATGGGACGGGCCCGCGGGGGAGGCTCGTGAGG
CCGCCGCTGCCACTGCCGGAGCGCTGAGGTTAGGGGCCAGCCGAGAGGCCTAGAAACACTGCCGC
TACCGCGGAACCGGAGGGACGTCNNTTCGGACGGCCGTAGTAGCCCGGGGCTCTCCGCCGCTGCC
TGGACCTCCCCCCGTGCGTCCCGGGCCGTCGCCCGCCCCCGCCGCGGNCCCTAGCTCGCAGCCCA
CTCCGCGCAGCCACAGATCATCTTCCGATTCTTTCCCAGGAGCTTCAAGTAGGGATATGTCCTCA
GCACCAACTACTCCTCCATCAGTGGGATAAAGTAGACGGGATTTTCTCGGAAGTCCGTCAGAAAA
AGCCAGACAGAAGAGGTCGCAAAGCTCCTCCCAGTTTCAGGTCTCAAGGCAAGCCCANTTGAGCT
CACGCCTCTGCCACTGCTGGAAAGACGTTNCNAACCNTCANAAGCAGCCTTGAAACTTGTTTCCT
NAAAGAAACTTCANCAGGGGCTGGTGTCCATTTTTTGGACCTTCATGGGANCNCGCCTATTCTGA
TTNTTAAAAATGGAAAAGAATACAAGGCGGGCTTCCNCTNTCTTTTAATTGAAACTNGGGTGGGG
AANTTACNATTTNACAAATTA 
 
Septin (Nedd 5) 
 
TACGATGTTCCAGATTACGCTAGCTTGGGTGGTCATATGGCCATGGAGGCCCCGGGGATCCGAAT
TCGCGGCCGCGTCGACCCTGACGAGCGTTCTCCCGGCGTGTGAGCGGATTAGACAGGNAAAATCA
AAGAAAAGATTGTTTTAAGGCNACCAACCAACTTTNTTTTTTTTAANNNCNAAAAACCCCCTGGG
CTNTTGTTNGGNATTTTNCNAAANTTTNCCCCCAATNCAANNTTN 
 
N-acetyllactosaminide alpha-1,3-galactosyltransferase 
Galactosyltransferase  
 
TCTATTCGATGATGAAGATACCCCACCAANCCCAAAAAAAGAGATCTCTATGGCTTACCCATACG
ATGTTCCAGATTACGCTAGCTTGGGTGGTCATATGGCCATGGAGGCCCCGGGGATCCGAATTCGC
GGCCGCGTCGACCAAAAAACCAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAGAAGAAAGCCACG
TGGGGCTGAGTAGTAAGATCATGTGAATGCCTTGAGAGCCCCACTCTCCTCAGCAGAAGCGCACG
GCTGGAGAACTGGGAGTCTCCCCACACGGTGAAGGGTGGAAACCAAAGTTTCACCATCTCTCTGC
CACTGCACAACACAGTGCAGAGCTTGCACACTGTGCTGCAGTTCANATCCAGGTCTCCACATGGA
GGCTTTGGGAACGAGGGGTGAGAGTGGATGGGCAGTGCCGACTTTGACAGCCTGAAGAGGATCTC
AGTCAGATGAGAAACAGCTTGATCCAGGGCCTGAAAGATTAGCTGTAACTGAAGTGCCCACGTCC
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CTAAAGACCGTCACTTTCTAGCTTGCTTCTGAGAAGGGGTGGACCAGCTGACTTTCCATGGAGAG
GGTTGGTGACAATGCCTTTGGTGGTTCCCCTCGTGCTNGTAGATCTGAATCCACTCTGCCCCCCN
TGCAACCTTTTCATTTGCTTTTTTGTTTTGGTTGGTTTTGCTTTTGCTTCTGGTTTTTGTTTGGT
TTTTTGTTTTCCTGGCCGNACTCTTTGGCAAAGGCAAGAGCANNTGCTGTTACAGGGCAGGCCAG
CCCCCACCTGGGNCTCTTGGCTACTGGATAGCCTCTTNCNATCN 
 
Syalyltransferase 
 
AATACTATCTTTCGATGATGAAGATACCCCACCAAACCCAAAAAAAGAGATCTCTATGGCTTACC
CATACGATGTTCCAGATTACGCTAGCTTGGGTGGTCATATGGCCATGGAGGCCCCGGGGTATCCG
AATTCGCGGCCGCGTCGACGCGCTCCCCGGCGGAGATGAGGAAACTGAGGCTCAGAGAGGTCACA
TGGCTTGCTCGAGGCCCCCCAGCCAGTAAGTGTGGACCCGACATTCGCACTGGCACCTGATACGC
TGTTCTGACCATGGCGTTCTCAGAGCAGGACCGTGACGGGCCTGACCGGGGGAACCGTAGTCCTG
GCTGAGGGCACTGCTCAGGCAAAGGTGTGACCCCACAACCCTGCCCCCCGGGCCACCTGCCGGAC
GCTGGCCTCTACCCTTCAGCAGACGCCGGAGAGAGATGAGTAGCAACAAAGAGCAGCGGTCAGCA
GTGTTTGTGATCCTCTTTGCCCTCATCACCATCCTCATCCTCTACAGCTCCAACAGTGCCAACGA
GGTCTTCCACTACGGCTCCCTGCGGGGCCGCACGCGTCGGCCAGTCAACCTCAAGAAGTGGAGTT
TTTCCAGCGCCTACTTCCCTTATCCTCGGGCAACAAGACGCTTGCCGTCCAGGGGCAANCCAGTG
TGNTGATCATTCACCAGCTTCCAGCCACNTGCTTGGGGCACNAAAACTGGGGCCCTNGAGATTTG
AGGCGGGGGTTGAGTGGCACCATTCCGCNATGAACGATGGCTTCCCACCTCNTNGGGTTACTNCN
GGCTGAANGTCTGGNAAACAAAACCNNCCTT 
 
Creatine kinase 
 
TCTTTCGATGATGAAGATACCCCACCAAACCCAAAAAAAGAGATCTCTATGGCTTACCCATACGA
TGTTCCAGATTACGCTAGCTTGGGTGGTCATATGGCCATGGAGGcCcCGGGGATCCGAATTCGCG
GCCGCGTCGACACCAGATCCTGCTCTGAATCTTTGTAGCCGCATCCCCAAGCCATGGCTGGTCCC
TTCTCCCGTCTGCTGTCTGCCCGCCCTGGACTCAGGCTCCTGGCTTTGGCTGGAGCTGGGTCTCT
CACCGCCGGGATTCTGCTCCGCCCGGAATCTGTAGGAGCTGCCGCTGCTGAACGGAGGAGACTGT
ATCCCCCGAGCGCTGAGTACCCAGACCTNNTTNNNNCACNACAACNGCNTGGCCAGTCACCTGAC
TCCAGNAGTCTATGCACGGNTCTGCGTACAAAGAACNACACCCACTTGGGTTGGACATCTAGAAT
CAAGTGCAATTCCAANACTGGGAGTTGGGACAACCCCTTGGCCCACCCCCTTTANTTCAAAGAAC
TTGTGGGGTCNANGGNTGGGCTGGGATNNATGAAGGAAGCACCCTNCTGCAGGGTAATTCTTNGC
TTNNAAACTTGTTTGTGGAACCCCTTGGTTNNATNCCAAGNAGNNGGGNAANTAAATTGGGAATT
NTAGAACCCCCCCCGGAAATNCACATATGGAAAGCCTACCNCCCCNACNCTTGAAACCCCTTTGG
AACTGTCCCNAAGTATATAAAGATTTCNCGATTTTCTGTGGNTTTATCCTTTTTGNAATGCAANC
ANGTNTANTGNNATTTTGGNTCTTTCNCACA 
 
Protein kinase A-β 
 
TTTAAAAGGAAAGCTACATGTTGCTTTTTGTAGTTTTGAGCAATATTTTTGCTGACCAGTGGCTT
GAAGATAAACTCTCTAATGATTATTTTTATTTTGAGTAGCTTGAATTCAGTTTTGCCAAAACTCT
TAGTAATTTTGAAGATGGAATGTCTTGTCAGCATGGGAATTTGCATAAGTAAAGATAACTTTTCA
GGGGTCACTGATGCAGCAGTGAGTCAGAGCGCCTAGAGAGCAGTGAGGACTCCTGGACGAGAGGC
TACGTTCCCCTGGGCCTTCTAGTGCTCTTCACTCCGTGAGATAGTAAGTGACCAGACAGATAAGT
GAGGGGCATGGCTCCTCGCCGCAGCTGTCTCCCTTGGTACCGACCTCTCTGTGGGCTGGAGAGAG
GCCTAAGGTTTCTGAGCCTTGGCTCTTCCATGGGGGCTTCAGCCAGTATTTGAGGAAAGTGTGAC
TGAGAAATGACACTTTGGGAGGTTTCTCCGTCCTCATCGGTGGGCTCTTAAGGGAAAAGAGCAAA
CGTGCATTTTGGATAANTGCTAAGTCAGCAGAAGCCTTGATACCTGCTTGCCAGCTTTANAGGTT
CTCTCCTTTAAAGGGAACTTGNTCTGTTTGCTTTGGGTTCGNACCAGGTTAGAAAACAAACTTGT
CTGTTTGCTTTGGTTCGTACCAGGTAAGAAAACA  
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TANK-binding kinase 
 
TCTNTTCGATGATGAANATCCCCACCAAACCCAANAAAAGAGATCTCTATGGCTTACCCATACGA
TGTTCCAGATTACGCTAGCTTGGGTGGTCATATGGCCATGGAGGCCCCGGGGATCCGAATTCGCG
GCCGCGTCGACCGAAGCCGGAAGTAGCCTGGGGCGCGAGAAGGCCCGGGAGCCGCGGGCTGTACG
CGGCGGACACTCGCGGGCATACATGCAAATCTCTTCTTCCCCCTTATCGTGAGGAGAAGCGCCTG
GACAAGCCGAGATGCAGAGCACCTCCAACCATCTGTGGCTCCTGTCTGATATCCTAGGCCAGGGG
GCCACTGCAAATGTCTTCCGAGGAAGGCATAAGAAAACTGGTGATCTCTATGCTGTCAAAGTATT
TAATAACATAAGCTTCCTTCGCCCAGTGGATGTTCAAATGAGAGAATTTGAAGTGTTAAAAAAAC
TCAATCACAAAAACATTGTCAAGTTATTTGCTATTGAAGAGGAGACAACAACAAGACATAAAGTG
CTTATTATGGAGTTTTGTCCCTGTGGGAGTTTATACACTGTTCTAGAGGAGCCGTCCAATGCGTA
TGGACTTCCAGAATCAGAATTTCTCATTGTCTTACGAGATGTGGTGGGCGGGATGAATCATCTCC
GAGAGAACGGCATAGTGCACCGAGATATCAAGCCAGGGCAACATCATGCGCGTCATAAGGGNAGG
ACGGCCAGTCTGGTGTACAAACTCACGGGATTTCGGCGCCGCTCGAAGAgCTGGAAGgANNNATG
AgCAgTTTTGTGTCTCTTGTA 
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